-
1
-
-
84865249952
-
Transcription factors: from enhancer binding to developmental control
-
doi: 10.1038/nrg3207.
-
Spitz F, Furlong EEM. Transcription factors: from enhancer binding to developmental control. Nat Rev Genet 2012, 13:613-626. doi: 10.1038/nrg3207.
-
(2012)
Nat Rev Genet
, vol.13
, pp. 613-626
-
-
Spitz, F.1
Furlong, E.E.M.2
-
2
-
-
84867396351
-
Mechanisms of DNA methylation and demethylation in mammals
-
doi: 10.1016/j.biochi.2012.05.016.
-
Auclair G, Weber M. Mechanisms of DNA methylation and demethylation in mammals. Biochimie 2012, 94:2202-2211. doi: 10.1016/j.biochi.2012.05.016.
-
(2012)
Biochimie
, vol.94
, pp. 2202-2211
-
-
Auclair, G.1
Weber, M.2
-
3
-
-
79961022522
-
DNA methylation status predicts cell type-specific enhancer activity
-
doi: 10.1038/emboj.2011.210.
-
Wiench M, John S, Baek S, Johnson TA, Sung M-H, Escobar T, Simmons CA, Pearce KH, Biddie SC, Sabo PJ, et al. DNA methylation status predicts cell type-specific enhancer activity. EMBO J 2011, 30:3028-3039. doi: 10.1038/emboj.2011.210.
-
(2011)
EMBO J
, vol.30
, pp. 3028-3039
-
-
Wiench, M.1
John, S.2
Baek, S.3
Johnson, T.A.4
Sung, M.-H.5
Escobar, T.6
Simmons, C.A.7
Pearce, K.H.8
Biddie, S.C.9
Sabo, P.J.10
-
4
-
-
0035839136
-
Translating the histone code
-
doi: 10.1126/science.1063127.
-
Jenuwein T, Allis CD. Translating the histone code. Science 2001, 293:1074-1080. doi: 10.1126/science.1063127.
-
(2001)
Science
, vol.293
, pp. 1074-1080
-
-
Jenuwein, T.1
Allis, C.D.2
-
5
-
-
84863770814
-
Cancer genetics and epigenetics: two sides of the same coin?
-
doi: 10.1016/j.ccr.2012.06.008.
-
You JS, Jones PA. Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 2012, 22:9-20. doi: 10.1016/j.ccr.2012.06.008.
-
(2012)
Cancer Cell
, vol.22
, pp. 9-20
-
-
You, J.S.1
Jones, P.A.2
-
6
-
-
33750352462
-
Transcriptional regulatory elements in the human genome
-
doi: 10.1146/annurev.genom.7.080505.115623.
-
Maston GA, Evans SK, Green MR. Transcriptional regulatory elements in the human genome. Annu Rev Genomics Hum Genet 2006, 7:29-59. doi: 10.1146/annurev.genom.7.080505.115623.
-
(2006)
Annu Rev Genomics Hum Genet
, vol.7
, pp. 29-59
-
-
Maston, G.A.1
Evans, S.K.2
Green, M.R.3
-
7
-
-
0020489781
-
Amount and distribution of 5-methylcytosine in human DNA from different types of tissues or cells
-
doi: 10.1093/nar/10.8.2709.
-
Ehrlich M, Gamasosa MA, Huang LH, Midgett RM, Kuo KC, Mccune RA, Gehrke C. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues or cells. Nucleic Acids Res 1982, 10:2709-2721. doi: 10.1093/nar/10.8.2709.
-
(1982)
Nucleic Acids Res
, vol.10
, pp. 2709-2721
-
-
Ehrlich, M.1
Gamasosa, M.A.2
Huang, L.H.3
Midgett, R.M.4
Kuo, K.C.5
Mccune, R.A.6
Gehrke, C.7
-
8
-
-
84855281409
-
Genomic distribution and inter-sample variation of non-CpG methylation across human cell types
-
doi: 10.1371/journal.pgen.1002389.
-
Ziller MJ, Müller F, Liao J, Zhang Y, Gu H, Bock C, Boyle P, Epstein CB, Bernstein BE, Lengauer T, et al. Genomic distribution and inter-sample variation of non-CpG methylation across human cell types. PLoS Genet 2011, 7:e1002389. doi: 10.1371/journal.pgen.1002389.
-
(2011)
PLoS Genet
, vol.7
-
-
Ziller, M.J.1
Müller, F.2
Liao, J.3
Zhang, Y.4
Gu, H.5
Bock, C.6
Boyle, P.7
Epstein, C.B.8
Bernstein, B.E.9
Lengauer, T.10
-
9
-
-
33745270104
-
Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b
-
doi: 10.1111/j.1365-2443.2006.00984.x.
-
Tsumura A, Hayakawa T, Kumaki Y, Takebayashi S-I, Sakaue M, Matsuoka C, Shimotohno K, Ishikawa F, Li E, Ueda HR, et al. Maintenance of self-renewal ability of mouse embryonic stem cells in the absence of DNA methyltransferases Dnmt1, Dnmt3a and Dnmt3b. Genes Cells 2006, 11:805-814. doi: 10.1111/j.1365-2443.2006.00984.x.
-
(2006)
Genes Cells
, vol.11
, pp. 805-814
-
-
Tsumura, A.1
Hayakawa, T.2
Kumaki, Y.3
Takebayashi, S.-I.4
Sakaue, M.5
Matsuoka, C.6
Shimotohno, K.7
Ishikawa, F.8
Li, E.9
Ueda, H.R.10
-
10
-
-
22844457491
-
DNA methylation and human disease
-
doi: 10.1038/nrg1655.
-
Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005, 6:597-610. doi: 10.1038/nrg1655.
-
(2005)
Nat Rev Genet
, vol.6
, pp. 597-610
-
-
Robertson, K.D.1
-
11
-
-
0024081657
-
Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter
-
Watt F, Molloy PL. Cytosine methylation prevents binding to DNA of a HeLa cell transcription factor required for optimal expression of the adenovirus major late promoter. Genes Dev 1988, 2:1136-1143.
-
(1988)
Genes Dev
, vol.2
, pp. 1136-1143
-
-
Watt, F.1
Molloy, P.L.2
-
12
-
-
0032574977
-
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex
-
doi: 10.1038/30764.
-
Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998, 393:386-389. doi: 10.1038/30764.
-
(1998)
Nature
, vol.393
, pp. 386-389
-
-
Nan, X.1
Ng, H.H.2
Johnson, C.A.3
Laherty, C.D.4
Turner, B.M.5
Eisenman, R.N.6
Bird, A.7
-
13
-
-
0025975985
-
DNA methylation inhibits tran-scription indirectly via a methyl-CpG binding protein
-
Boyes J, Bird A. DNA methylation inhibits tran-scription indirectly via a methyl-CpG binding protein. Cell 1991, 64:1123-1134.
-
(1991)
Cell
, vol.64
, pp. 1123-1134
-
-
Boyes, J.1
Bird, A.2
-
14
-
-
51649083501
-
A microRNA DNA methylation signature for human cancer metastasis
-
doi: 10.1073/pnas.0803055105.
-
Lujambio A, Calin GA, Villanueva A, Ropero S, Sánchez-Céspedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso MS, Faller WJ, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA 2008, 105:13556-13561. doi: 10.1073/pnas.0803055105.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 13556-13561
-
-
Lujambio, A.1
Calin, G.A.2
Villanueva, A.3
Ropero, S.4
Sánchez-Céspedes, M.5
Blanco, D.6
Montuenga, L.M.7
Rossi, S.8
Nicoloso, M.S.9
Faller, W.J.10
-
15
-
-
0036274359
-
The fundamental role of epigenetic events in cancer
-
doi: 10.1038/nrg816.
-
Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002, 3:415-428. doi: 10.1038/nrg816.
-
(2002)
Nat Rev Genet
, vol.3
, pp. 415-428
-
-
Jones, P.A.1
Baylin, S.B.2
-
16
-
-
84866844032
-
Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns
-
doi: 10.1186/gb-2012-13-10-r84.
-
Sproul D, Kitchen RR, Nestor CE, Dixon JM, Sims AH, Harrison DJ, Ramsahoye BH, Meehan RR. Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns. Genome Biol 2012, 13:R84. doi: 10.1186/gb-2012-13-10-r84.
-
(2012)
Genome Biol
, vol.13
-
-
Sproul, D.1
Kitchen, R.R.2
Nestor, C.E.3
Dixon, J.M.4
Sims, A.H.5
Harrison, D.J.6
Ramsahoye, B.H.7
Meehan, R.R.8
-
17
-
-
36849059066
-
LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability
-
doi: 10.1371/journal.pone.0000399.
-
Estécio MRH, Gharibyan V, Shen L, Ibrahim AEK, Doshi K, He R, Jelinek J, Yang AS, Yan PS, Huang TH-M, et al. LINE-1 hypomethylation in cancer is highly variable and inversely correlated with microsatellite instability. PLoS One 2007, 2:e399. doi: 10.1371/journal.pone.0000399.
-
(2007)
PLoS One
, vol.2
-
-
Estécio, M.R.H.1
Gharibyan, V.2
Shen, L.3
Ibrahim, A.E.K.4
Doshi, K.5
He, R.6
Jelinek, J.7
Yang, A.S.8
Yan, P.S.9
Huang, T.-M.10
-
18
-
-
84859083304
-
Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats
-
doi: 10.1371/journal.pone.0033213.
-
Saied MH, Marzec J, Khalid S, Smith P, Down TA, Rakyan VK, Molloy G, Raghavan M, Debernardi S, Young BD. Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats. PLoS One 2012, 7:e33213. doi: 10.1371/journal.pone.0033213.
-
(2012)
PLoS One
, vol.7
-
-
Saied, M.H.1
Marzec, J.2
Khalid, S.3
Smith, P.4
Down, T.A.5
Rakyan, V.K.6
Molloy, G.7
Raghavan, M.8
Debernardi, S.9
Young, B.D.10
-
19
-
-
84861483398
-
Methylation profile of DNA repetitive elements in human testicular germ cell tumor
-
doi: 10.1002/mc.20831.
-
Ushida H, Kawakami T, Minami K, Chano T, Okabe H, Okada Y, Okamoto K. Methylation profile of DNA repetitive elements in human testicular germ cell tumor. Mol Carcinog 2012, 51:711-722. doi: 10.1002/mc.20831.
-
(2012)
Mol Carcinog
, vol.51
, pp. 711-722
-
-
Ushida, H.1
Kawakami, T.2
Minami, K.3
Chano, T.4
Okabe, H.5
Okada, Y.6
Okamoto, K.7
-
20
-
-
77956838913
-
Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer
-
doi: 10.1016/j.semcancer.2010.05.005.
-
Romanish MT, Cohen CJ, Mager DL. Potential mechanisms of endogenous retroviral-mediated genomic instability in human cancer. Semin Cancer Biol 2010, 20:246-253. doi: 10.1016/j.semcancer.2010.05.005.
-
(2010)
Semin Cancer Biol
, vol.20
, pp. 246-253
-
-
Romanish, M.T.1
Cohen, C.J.2
Mager, D.L.3
-
21
-
-
32344450824
-
Genomic {DNA} methylation: the mark and its mediators
-
doi: 10.1016/j.leukres.2011.07.013.
-
Klose RJ, Bird AP. Genomic {DNA} methylation: the mark and its mediators. Trends Biochem Sci 2006, 31:89-97. doi: 10.1016/j.leukres.2011.07.013.
-
(2006)
Trends Biochem Sci
, vol.31
, pp. 89-97
-
-
Klose, R.J.1
Bird, A.P.2
-
22
-
-
0037456636
-
Mutation of the {DNA} methyltransferase (DNMT) 1 gene in human colorectal cancers
-
doi: 10.1016/S0304-3835(02)00689-4.
-
Kanai Y, Ushijima S, Nakanishi Y, Sakamoto M, Hirohashi S. Mutation of the {DNA} methyltransferase (DNMT) 1 gene in human colorectal cancers. Cancer Lett 2003, 192:75-82. doi: 10.1016/S0304-3835(02)00689-4.
-
(2003)
Cancer Lett
, vol.192
, pp. 75-82
-
-
Kanai, Y.1
Ushijima, S.2
Nakanishi, Y.3
Sakamoto, M.4
Hirohashi, S.5
-
23
-
-
84868554484
-
Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing
-
doi: 10.1182/blood-2011-12-401471.
-
Dolnik A, Engelmann JC, Scharfenberger-Schmeer M, Mauch J, Kelkenberg-Schade S, Haldemann B, Fries T, Krönke J, Kühn MWM, Paschka P, et al. Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing. Blood 2012, 120:e83-e92. doi: 10.1182/blood-2011-12-401471.
-
(2012)
Blood
, vol.120
-
-
Dolnik, A.1
Engelmann, J.C.2
Scharfenberger-Schmeer, M.3
Mauch, J.4
Kelkenberg-Schade, S.5
Haldemann, B.6
Fries, T.7
Krönke, J.8
Kühn, M.W.M.9
Paschka, P.10
-
24
-
-
79953176952
-
Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia
-
doi: 10.1038/ng.788.
-
Yan X-J, Xu J, Gu Z-H, Pan C-M, Lu G, Shen Y, Shi J-Y, Zhu Y-M, Tang L, Zhang X-W, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet 2011, 43:309-315. doi: 10.1038/ng.788.
-
(2011)
Nat Genet
, vol.43
, pp. 309-315
-
-
Yan, X.-J.1
Xu, J.2
Gu, Z.-H.3
Pan, C.-M.4
Lu, G.5
Shen, Y.6
Shi, J.-Y.7
Zhu, Y.-M.8
Tang, L.9
Zhang, X.-W.10
-
25
-
-
79960255863
-
Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
-
doi: 10.1038/leu.2011.44.
-
Walter MJ, Ding L, Shen D, Shao J, Grillot M, McLellan M, Fulton R, Schmidt H, Kalicki-Veizer J, O'Laughlin M, et al. Recurrent DNMT3A mutations in patients with myelodysplastic syndromes. Leukemia 2011, 25:1153-1158. doi: 10.1038/leu.2011.44.
-
(2011)
Leukemia
, vol.25
, pp. 1153-1158
-
-
Walter, M.J.1
Ding, L.2
Shen, D.3
Shao, J.4
Grillot, M.5
McLellan, M.6
Fulton, R.7
Schmidt, H.8
Kalicki-Veizer, J.9
O'Laughlin, M.10
-
26
-
-
84866077973
-
Mutations in DNA Methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation
-
doi: 10.1074/jbc.M112.366625.
-
Holz-Schietinger C, Matje DM, Reich NO. Mutations in DNA Methyltransferase (DNMT3A) observed in acute myeloid leukemia patients disrupt processive methylation. J Biol Chem 2012, 287:30941-30951. doi: 10.1074/jbc.M112.366625.
-
(2012)
J Biol Chem
, vol.287
, pp. 30941-30951
-
-
Holz-Schietinger, C.1
Matje, D.M.2
Reich, N.O.3
-
27
-
-
79960098405
-
Differential recruitment of methyl CpG-binding domain factors and DNA methyltransferases by the orphan receptor germ cell nuclear factor initiates the repression and silencing of Oct4
-
doi: 10.1002/stem.652.
-
Gu P, Xu X, Le Menuet D, Chung AC-K, Cooney AJ. Differential recruitment of methyl CpG-binding domain factors and DNA methyltransferases by the orphan receptor germ cell nuclear factor initiates the repression and silencing of Oct4. Stem Cells 2011, 29:1041-1051. doi: 10.1002/stem.652.
-
(2011)
Stem Cells
, vol.29
, pp. 1041-1051
-
-
Gu, P.1
Xu, X.2
Le Menuet, D.3
Chung, A.-K.4
Cooney, A.J.5
-
28
-
-
84866501823
-
Clinicopathologic significance of DNA methyltransferase 1, 3a, and 3b overexpression in Tunisian breast cancers
-
doi: 10.1016/j.humpath.2011.12.022.
-
Ben Gacem R, Hachana M, Ziadi S, Ben Abdelkarim S, Hidar S, Trimeche M. Clinicopathologic significance of DNA methyltransferase 1, 3a, and 3b overexpression in Tunisian breast cancers. Hum Pathol 2012, 43:1731-1738. doi: 10.1016/j.humpath.2011.12.022.
-
(2012)
Hum Pathol
, vol.43
, pp. 1731-1738
-
-
Ben Gacem, R.1
Hachana, M.2
Ziadi, S.3
Ben Abdelkarim, S.4
Hidar, S.5
Trimeche, M.6
-
29
-
-
80555135400
-
Expression and function role of DNA methyltransferase 1 in human bladder cancer
-
doi: 10.1002/cncr.26150.
-
Wu CT, Wu CF, Lu CH, Lin CC, Chen WC, Lin PY, Chen MF. Expression and function role of DNA methyltransferase 1 in human bladder cancer. Cancer 2011, 117:5221-5233. doi: 10.1002/cncr.26150.
-
(2011)
Cancer
, vol.117
, pp. 5221-5233
-
-
Wu, C.T.1
Wu, C.F.2
Lu, C.H.3
Lin, C.C.4
Chen, W.C.5
Lin, P.Y.6
Chen, M.F.7
-
30
-
-
80053097241
-
Clinical significance of the expression of DNA methyltransferase proteins in gastric cancer
-
doi: 10.3892/mmr.2011.578.
-
Yang J, Wei XW, Wu QX, Xu Z, Gu DY, Jin Y, Shen Y, Huang HY, Fan H, Chen JF. Clinical significance of the expression of DNA methyltransferase proteins in gastric cancer. Mol Med Rep 2011, 4:1139-1143. doi: 10.3892/mmr.2011.578.
-
(2011)
Mol Med Rep
, vol.4
, pp. 1139-1143
-
-
Yang, J.1
Wei, X.W.2
Wu, Q.X.3
Xu, Z.4
Gu, D.Y.5
Jin, Y.6
Shen, Y.7
Huang, H.Y.8
Fan, H.9
Chen, J.F.10
-
31
-
-
80053135096
-
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A
-
doi: 10.1182/blood-2010-10-311019.
-
Jankowska AM, Makishima H, Tiu RV, Szpurka H, Huang Y, Traina F, Visconte V, Sugimoto Y, Prince C, O'Keefe C, et al. Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A. Blood 2011, 118:3932-3941. doi: 10.1182/blood-2010-10-311019.
-
(2011)
Blood
, vol.118
, pp. 3932-3941
-
-
Jankowska, A.M.1
Makishima, H.2
Tiu, R.V.3
Szpurka, H.4
Huang, Y.5
Traina, F.6
Visconte, V.7
Sugimoto, Y.8
Prince, C.9
O'Keefe, C.10
-
32
-
-
84872655929
-
Mutational analysis of DNMT3A gene in acute leukemias and common solid cancers
-
doi: 10.1111/j.1600-0463.2012.02940.x.
-
Kim MS, Kim YR, Yoo NJ, Lee SH. Mutational analysis of DNMT3A gene in acute leukemias and common solid cancers. APMIS 2013, 121:85-94. doi: 10.1111/j.1600-0463.2012.02940.x.
-
(2013)
APMIS
, vol.121
, pp. 85-94
-
-
Kim, M.S.1
Kim, Y.R.2
Yoo, N.J.3
Lee, S.H.4
-
33
-
-
84860763627
-
Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma
-
doi: 10.1007/s12094-012-0770-x.
-
Zhang JJ, Zhu Y, Wu JL, Liang WB, Zhu R, Xu ZK, Du Q, Miao Y. Association of increased DNA methyltransferase expression with carcinogenesis and poor prognosis in pancreatic ductal adenocarcinoma. Clin Transl Oncol 2012, 14:116-124. doi: 10.1007/s12094-012-0770-x.
-
(2012)
Clin Transl Oncol
, vol.14
, pp. 116-124
-
-
Zhang, J.J.1
Zhu, Y.2
Wu, J.L.3
Liang, W.B.4
Zhu, R.5
Xu, Z.K.6
Du, Q.7
Miao, Y.8
-
34
-
-
84858173501
-
Increased DNA methyltransferase activity and DNA methylation following epidermal growth factor stimulation in ovarian cancer cells
-
doi: 10.4161/epi.7.3.19273.
-
Samudio-Ruiz SL, Hudson LG. Increased DNA methyltransferase activity and DNA methylation following epidermal growth factor stimulation in ovarian cancer cells. Epigenetics 2012, 7:216-224. doi: 10.4161/epi.7.3.19273.
-
(2012)
Epigenetics
, vol.7
, pp. 216-224
-
-
Samudio-Ruiz, S.L.1
Hudson, L.G.2
-
35
-
-
84870864252
-
High DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemia
-
doi: 10.1371/journal.pone.0051527.
-
Hayette S, Thomas X, Jallades L, Chabane K, Charlot C, Tigaud I, Gazzo S, Morisset S, Cornillet-Lefebvre P, Plesa A, et al. High DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemia. PLoS One 2012, 7:e51527. doi: 10.1371/journal.pone.0051527.
-
(2012)
PLoS One
, vol.7
-
-
Hayette, S.1
Thomas, X.2
Jallades, L.3
Chabane, K.4
Charlot, C.5
Tigaud, I.6
Gazzo, S.7
Morisset, S.8
Cornillet-Lefebvre, P.9
Plesa, A.10
-
36
-
-
33644767915
-
The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth
-
doi: 10.1038/sj.onc.1209179.
-
Bernard D, Gil J, Dumont P, Rizzo S, Monté D, Quatannens B, Hudson D, Visakorpi T, Fuks F, de Launoit Y. The methyl-CpG-binding protein MECP2 is required for prostate cancer cell growth. Oncogene 2005, 25:1358. doi: 10.1038/sj.onc.1209179.
-
(2005)
Oncogene
, vol.25
, pp. 1358
-
-
Bernard, D.1
Gil, J.2
Dumont, P.3
Rizzo, S.4
Monté, D.5
Quatannens, B.6
Hudson, D.7
Visakorpi, T.8
Fuks, F.9
de Launoit, Y.10
-
37
-
-
84877762573
-
Up-regulation of MBD1 promotes pancreatic cancer cell epithelial-mesenchymal transition and invasion by epigenetic down-regulation of E-cadherin
-
doi: 10.2174/156652413805076740.
-
Xu J, Zhu W, Xu W, Yao W, Zhang B, Xu Y, Ji S, Liu C, Long J, Ni Q, et al. Up-regulation of MBD1 promotes pancreatic cancer cell epithelial-mesenchymal transition and invasion by epigenetic down-regulation of E-cadherin. Curr Mol Med 2013, 13:387-400. doi: 10.2174/156652413805076740.
-
(2013)
Curr Mol Med
, vol.13
, pp. 387-400
-
-
Xu, J.1
Zhu, W.2
Xu, W.3
Yao, W.4
Zhang, B.5
Xu, Y.6
Ji, S.7
Liu, C.8
Long, J.9
Ni, Q.10
-
38
-
-
80052193218
-
Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1
-
doi: 10.1158/0008-5472.CAN-11-1157.
-
Zhu D, Hunter SB, Vertino PM, Meir EGV. Overexpression of MBD2 in glioblastoma maintains epigenetic silencing and inhibits the antiangiogenic function of the tumor suppressor gene BAI1. Cancer Res 2011, 71:5859-5870. doi: 10.1158/0008-5472.CAN-11-1157.
-
(2011)
Cancer Res
, vol.71
, pp. 5859-5870
-
-
Zhu, D.1
Hunter, S.B.2
Vertino, P.M.3
Meir, E.G.V.4
-
39
-
-
0037350661
-
TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23)
-
doi: 10.1038/sj.leu.2402834.
-
Lorsbach B, Moore J, Mathew S, Raimondi C, Mukatira T, Downing R. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia 2003, 17:637-641. doi: 10.1038/sj.leu.2402834.
-
(2003)
Leukemia
, vol.17
, pp. 637-641
-
-
Lorsbach, B.1
Moore, J.2
Mathew, S.3
Raimondi, C.4
Mukatira, T.5
Downing, R.6
-
40
-
-
67651065502
-
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
-
doi: 10.1182/blood-2009-03-210039.
-
Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M, Malinge S, Yao J, Kilpivaara O, Bhat R, et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 2009, 114:144-147. doi: 10.1182/blood-2009-03-210039.
-
(2009)
Blood
, vol.114
, pp. 144-147
-
-
Abdel-Wahab, O.1
Mullally, A.2
Hedvat, C.3
Garcia-Manero, G.4
Patel, J.5
Wadleigh, M.6
Malinge, S.7
Yao, J.8
Kilpivaara, O.9
Bhat, R.10
-
41
-
-
67650924270
-
Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
-
doi: 10.1038/leu.2009.59.
-
Tefferi A, Lim H, Abdel-Wahab O, Lasho L, Patel J, Patnaik M, Hanson A, Pardanani A, Gilliland G, Levine L. Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML. Leukemia 2009, 23:1343-1345. doi: 10.1038/leu.2009.59.
-
(2009)
Leukemia
, vol.23
, pp. 1343-1345
-
-
Tefferi, A.1
Lim, H.2
Abdel-Wahab, O.3
Lasho, L.4
Patel, J.5
Patnaik, M.6
Hanson, A.7
Pardanani, A.8
Gilliland, G.9
Levine, L.10
-
42
-
-
84866419591
-
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma
-
doi: 10.1016/j.cell.2012.07.033.
-
Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, Xu W, Tan L, Hu Y, Zhan Q, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012, 150:1135-1146. doi: 10.1016/j.cell.2012.07.033.
-
(2012)
Cell
, vol.150
, pp. 1135-1146
-
-
Lian, C.G.1
Xu, Y.2
Ceol, C.3
Wu, F.4
Larson, A.5
Dresser, K.6
Xu, W.7
Tan, L.8
Hu, Y.9
Zhan, Q.10
-
43
-
-
80053948896
-
Decreased {TET2} gene expression during chronic myeloid leukemia progression
-
doi: 10.1016/j.leukres.2011.07.013.
-
Albano A, Anelli A, Zagaria Z, Coccaro C, Minervini M, Rossi AR, Specchia S. Decreased {TET2} gene expression during chronic myeloid leukemia progression. Leuk Res 2011, 35:e220-e222. doi: 10.1016/j.leukres.2011.07.013.
-
(2011)
Leuk Res
, vol.35
-
-
Albano, A.1
Anelli, A.2
Zagaria, Z.3
Coccaro, C.4
Minervini, M.5
Rossi, A.R.6
Specchia, S.7
-
44
-
-
70149093912
-
Recurring mutations found by sequencing an acute myeloid leukemia genome
-
doi: 10.1056/NEJMoa0903840.
-
Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, Koboldt DC, Fulton RS, Delehaunty KD, McGrath SD, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009, 361:1058-1066. doi: 10.1056/NEJMoa0903840.
-
(2009)
N Engl J Med
, vol.361
, pp. 1058-1066
-
-
Mardis, E.R.1
Ding, L.2
Dooling, D.J.3
Larson, D.E.4
McLellan, M.D.5
Chen, K.6
Koboldt, D.C.7
Fulton, R.S.8
Delehaunty, K.D.9
McGrath, S.D.10
-
45
-
-
52949127312
-
An integrated genomic analysis of human glioblastoma multiforme
-
doi: 10.1126/science.1164382.
-
Parsons DW, Jones S, Zhang X, Lin JC-H, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu I-M, Gallia GL, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321:1807-1812. doi: 10.1126/science.1164382.
-
(2008)
Science
, vol.321
, pp. 1807-1812
-
-
Parsons, D.W.1
Jones, S.2
Zhang, X.3
Lin, J.-H.4
Leary, R.J.5
Angenendt, P.6
Mankoo, P.7
Carter, H.8
Siu, I.-M.9
Gallia, G.L.10
-
46
-
-
77649305610
-
The common feature of leukemia-associated {IDH1} and {IDH2} mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate
-
doi: 10.1016/j.ccr.2010.01.020.
-
Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA, Cross JR, Fantin VR, Hedvat CV, Perl AE, et al. The common feature of leukemia-associated {IDH1} and {IDH2} mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 2010, 17:225-234. doi: 10.1016/j.ccr.2010.01.020.
-
(2010)
Cancer Cell
, vol.17
, pp. 225-234
-
-
Ward, P.S.1
Patel, J.2
Wise, D.R.3
Abdel-Wahab, O.4
Bennett, B.D.5
Coller, H.A.6
Cross, J.R.7
Fantin, V.R.8
Hedvat, C.V.9
Perl, A.E.10
-
47
-
-
84861311139
-
IDH mutations: new genetic signatures in cholangiocarcinoma and therapeutic implications
-
doi: 10.1586/era.12.32.
-
Borger DR, Zhu AX. IDH mutations: new genetic signatures in cholangiocarcinoma and therapeutic implications. Expert Rev Anticancer Ther 2012, 12:543-546. doi: 10.1586/era.12.32.
-
(2012)
Expert Rev Anticancer Ther
, vol.12
, pp. 543-546
-
-
Borger, D.R.1
Zhu, A.X.2
-
48
-
-
84865231966
-
IDH mutation status in prostate cancer
-
doi: 10.1038/onc.2011.546.
-
Ghiam F, Cairns A, Thoms J, Dal Pra A, Ahmed O, Meng A, Mak W, Bristow G. IDH mutation status in prostate cancer. Oncogene 2012, 31:3826. doi: 10.1038/onc.2011.546.
-
(2012)
Oncogene
, vol.31
, pp. 3826
-
-
Ghiam, F.1
Cairns, A.2
Thoms, J.3
Dal Pra, A.4
Ahmed, O.5
Meng, A.6
Mak, W.7
Bristow, G.8
-
49
-
-
77952536841
-
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study
-
doi: 10.1200/JCO.2009.27.3730.
-
Marcucci G, Maharry K, Wu Y-Z, Radmacher MD, Mrózek K, Margeson D, Holland KB, Whitman SP, Becker H, Schwind S, et al. IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study. J Clin Oncol 2010, 28:2348-2355. doi: 10.1200/JCO.2009.27.3730.
-
(2010)
J Clin Oncol
, vol.28
, pp. 2348-2355
-
-
Marcucci, G.1
Maharry, K.2
Wu, Y.-Z.3
Radmacher, M.D.4
Mrózek, K.5
Margeson, D.6
Holland, K.B.7
Whitman, S.P.8
Becker, H.9
Schwind, S.10
-
50
-
-
84864643049
-
The role of DNA methyltransferase 3b in esophageal squamous cell carcinoma
-
doi: 10.1002/cncr.26736.
-
Chen MF, Lu MS, Lin PY, Chen PT, Chen WC, Lee KD. The role of DNA methyltransferase 3b in esophageal squamous cell carcinoma. Cancer 2012, 118:4074-4089. doi: 10.1002/cncr.26736.
-
(2012)
Cancer
, vol.118
, pp. 4074-4089
-
-
Chen, M.F.1
Lu, M.S.2
Lin, P.Y.3
Chen, P.T.4
Chen, W.C.5
Lee, K.D.6
-
51
-
-
69249220176
-
DNA methylation and methyl-CpG binding proteins: developmental requirements and function
-
doi: 10.1007/s00412-009-0221-9.
-
Bogdanović O, Veenstra GJC. DNA methylation and methyl-CpG binding proteins: developmental requirements and function. Chromosoma 2009, 118:549-565. doi: 10.1007/s00412-009-0221-9.
-
(2009)
Chromosoma
, vol.118
, pp. 549-565
-
-
Bogdanović, O.1
Veenstra, G.J.C.2
-
52
-
-
66149146320
-
Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1
-
doi: 10.1126/science.1170116.
-
Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935. doi: 10.1126/science.1170116.
-
(2009)
Science
, vol.324
, pp. 930-935
-
-
Tahiliani, M.1
Koh, K.P.2
Shen, Y.3
Pastor, W.A.4
Bandukwala, H.5
Brudno, Y.6
Agarwal, S.7
Iyer, L.M.8
Liu, D.R.9
Aravind, L.10
-
53
-
-
82955207588
-
Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation
-
doi: 10.1101/gad.179184.111.
-
Wu H, Zhang Y. Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev 2011, 25:2436-2452. doi: 10.1101/gad.179184.111.
-
(2011)
Genes Dev
, vol.25
, pp. 2436-2452
-
-
Wu, H.1
Zhang, Y.2
-
54
-
-
80052933429
-
DNA demethylation dynamics
-
doi: 10.1016/j.cell.2011.08.042.
-
Bhutani N, Burns DM, Blau HM. DNA demethylation dynamics. Cell 2011, 146:866-872. doi: 10.1016/j.cell.2011.08.042.
-
(2011)
Cell
, vol.146
, pp. 866-872
-
-
Bhutani, N.1
Burns, D.M.2
Blau, H.M.3
-
55
-
-
78651330430
-
COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer
-
doi: 10.1093/nar/gkq929.
-
Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, Jia M, Shepherd R, Leung K, Menzies A, et al. COSMIC: mining complete cancer genomes in the catalogue of somatic mutations in cancer. Nucleic Acids Res 2011, 39:D945-D950. doi: 10.1093/nar/gkq929.
-
(2011)
Nucleic Acids Res
, vol.39
-
-
Forbes, S.A.1
Bindal, N.2
Bamford, S.3
Cole, C.4
Kok, C.Y.5
Beare, D.6
Jia, M.7
Shepherd, R.8
Leung, K.9
Menzies, A.10
-
56
-
-
78650175023
-
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
-
doi: 10.1038/nature09586.
-
Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, Bandukwala HS, An J, Lamperti ED, Koh KP, Ganetzky R, et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010, 468:839-843. doi: 10.1038/nature09586.
-
(2010)
Nature
, vol.468
, pp. 839-843
-
-
Ko, M.1
Huang, Y.2
Jankowska, A.M.3
Pape, U.J.4
Tahiliani, M.5
Bandukwala, H.S.6
An, J.7
Lamperti, E.D.8
Koh, K.P.9
Ganetzky, R.10
-
57
-
-
84862266735
-
TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML Study Group
-
doi: 10.1200/JCO.2011.39.2886.
-
Gaidzik VI, Paschka P, Späth D, Habdank M, Köhne C-H, Germing U, Lilienfeld-Toal MV, Held G, Horst H-A, Haase D, et al. TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML Study Group. J Clin Oncol 2012, 30:1350-1357. doi: 10.1200/JCO.2011.39.2886.
-
(2012)
J Clin Oncol
, vol.30
, pp. 1350-1357
-
-
Gaidzik, V.I.1
Paschka, P.2
Späth, D.3
Habdank, M.4
Köhne, C.-H.5
Germing, U.6
Lilienfeld-Toal, M.V.7
Held, G.8
Horst, H.-A.9
Haase, D.10
-
58
-
-
84856657348
-
TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia
-
doi: 10.1371/journal.pone.0031605.
-
Pérez C, Martínez-Calle N, Martín-Subero JI, Segura V, Delabesse E, Fernandez-Mercado M, Garate L, Alvarez S, Rifon J, Varea S, et al. TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia. PLoS One 2012, 7:e31605. doi: 10.1371/journal.pone.0031605.
-
(2012)
PLoS One
, vol.7
-
-
Pérez, C.1
Martínez-Calle, N.2
Martín-Subero, J.I.3
Segura, V.4
Delabesse, E.5
Fernandez-Mercado, M.6
Garate, L.7
Alvarez, S.8
Rifon, J.9
Varea, S.10
-
59
-
-
84857150890
-
Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia
-
doi: 10.4161/epi.7.2.19015.
-
Yamazaki J, Taby R, Vasanthakumar A, Macrae T, Ostler KR, Shen L, Kantarjian HM, Estecio MR, Jelinek J, Godley LA, et al. Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia. Epigenetics 2012, 7:201-207. doi: 10.4161/epi.7.2.19015.
-
(2012)
Epigenetics
, vol.7
, pp. 201-207
-
-
Yamazaki, J.1
Taby, R.2
Vasanthakumar, A.3
Macrae, T.4
Ostler, K.R.5
Shen, L.6
Kantarjian, H.M.7
Estecio, M.R.8
Jelinek, J.9
Godley, L.A.10
-
60
-
-
79958226901
-
IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours
-
doi: 10.1002/path.2913.
-
Amary MF, Bacsi K, Maggiani F, Damato S, Halai D, Berisha F, Pollock R, O'Donnell P, Grigoriadis A, Diss T, et al. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours. J Pathol 2011, 224:334-343. doi: 10.1002/path.2913.
-
(2011)
J Pathol
, vol.224
, pp. 334-343
-
-
Amary, M.F.1
Bacsi, K.2
Maggiani, F.3
Damato, S.4
Halai, D.5
Berisha, F.6
Pollock, R.7
O'Donnell, P.8
Grigoriadis, A.9
Diss, T.10
-
61
-
-
78650019179
-
Leukemic {IDH1} and {IDH2} mutations result in a hypermethylation phenotype, disrupt {TET2} function, and impair hematopoietic differentiation
-
doi: 10.1016/j.ccr.2010.11.015.
-
Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, et al. Leukemic {IDH1} and {IDH2} mutations result in a hypermethylation phenotype, disrupt {TET2} function, and impair hematopoietic differentiation. Cancer Cell 2010, 18:553-567. doi: 10.1016/j.ccr.2010.11.015.
-
(2010)
Cancer Cell
, vol.18
, pp. 553-567
-
-
Figueroa, M.E.1
Abdel-Wahab, O.2
Lu, C.3
Ward, P.S.4
Patel, J.5
Shih, A.6
Li, Y.7
Bhagwat, N.8
Vasanthakumar, A.9
Fernandez, H.F.10
-
62
-
-
84858796263
-
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
-
doi: 10.1038/nature10866.
-
Turcan S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E, Campos C, Fabius AWM, Lu C, Ward PS, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 2012, 483:479-483. doi: 10.1038/nature10866.
-
(2012)
Nature
, vol.483
, pp. 479-483
-
-
Turcan, S.1
Rohle, D.2
Goenka, A.3
Walsh, L.A.4
Fang, F.5
Yilmaz, E.6
Campos, C.7
Fabius, A.W.M.8
Lu, C.9
Ward, P.S.10
-
63
-
-
84875496294
-
(R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible
-
doi: 10.1126/science.1231677.
-
Losman J-A, Looper RE, Koivunen P, Lee S, Schneider RK, McMahon C, Cowley GS, Root DE, Ebert BL, Kaelin WG. (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science 2013, 339:1621-1625. doi: 10.1126/science.1231677.
-
(2013)
Science
, vol.339
, pp. 1621-1625
-
-
Losman, J.-A.1
Looper, R.E.2
Koivunen, P.3
Lee, S.4
Schneider, R.K.5
McMahon, C.6
Cowley, G.S.7
Root, D.E.8
Ebert, B.L.9
Kaelin, W.G.10
-
64
-
-
77952307741
-
Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control
-
doi: 10.1093/nar/gkp1214.
-
Gimenez J, Montgiraud C, Pichon J-P, Bonnaud B, Arsac M, Ruel K, Bouton O, Mallet F. Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control. Nucleic Acids Res 2010, 38:2229-2246. doi: 10.1093/nar/gkp1214.
-
(2010)
Nucleic Acids Res
, vol.38
, pp. 2229-2246
-
-
Gimenez, J.1
Montgiraud, C.2
Pichon, J.-P.3
Bonnaud, B.4
Arsac, M.5
Ruel, K.6
Bouton, O.7
Mallet, F.8
-
65
-
-
38049164130
-
Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice
-
doi: 10.1038/sj.onc.1210631.
-
Howard G, Eiges R, Gaudet F, Jaenisch R, Eden A. Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene 2008, 27:404-408. doi: 10.1038/sj.onc.1210631.
-
(2008)
Oncogene
, vol.27
, pp. 404-408
-
-
Howard, G.1
Eiges, R.2
Gaudet, F.3
Jaenisch, R.4
Eden, A.5
-
66
-
-
77952190003
-
Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma
-
doi: 10.1038/nm.2129.
-
Lamprecht B, Walter K, Kreher S, Kumar R, Hummel M, Lenze D, Köchert K, Bouhlel MA, Richter J, Soler E, et al. Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat Med 2010, 16:571-579. doi: 10.1038/nm.2129.
-
(2010)
Nat Med
, vol.16
, pp. 571-579
-
-
Lamprecht, B.1
Walter, K.2
Kreher, S.3
Kumar, R.4
Hummel, M.5
Lenze, D.6
Köchert, K.7
Bouhlel, M.A.8
Richter, J.9
Soler, E.10
-
67
-
-
33748983029
-
Transcriptional control of the HERV-H LTR element of the GSDML gene in human tissues and cancer cells
-
doi: 10.1007/s00705-006-0764-5.
-
Sin H-S, Huh J-W, Kim D-S, Kang DW, Min DS, Kim T-H, Ha H-S, Kim H-H, Lee S-Y, Kim H-S. Transcriptional control of the HERV-H LTR element of the GSDML gene in human tissues and cancer cells. Arch Virol 2006, 151:1985-1994. doi: 10.1007/s00705-006-0764-5.
-
(2006)
Arch Virol
, vol.151
, pp. 1985-1994
-
-
Sin, H.-S.1
Huh, J.-W.2
Kim, D.-S.3
Kang, D.W.4
Min, D.S.5
Kim, T.-H.6
Ha, H.-S.7
Kim, H.-H.8
Lee, S.-Y.9
Kim, H.-S.10
-
68
-
-
33845493042
-
Endogenous retrovirus-related sequences provide an alternative transcript of MCJ genes in human tissues and cancer cells
-
Sin H-S, Huh J-W, Kim D-S, Kim T-H, Ha H-S, Kim W-Y, Park H-K, Kim C-M, Kim H-S. Endogenous retrovirus-related sequences provide an alternative transcript of MCJ genes in human tissues and cancer cells. Genes Genet Syst 2006, 81:333-339.
-
(2006)
Genes Genet Syst
, vol.81
, pp. 333-339
-
-
Sin, H.-S.1
Huh, J.-W.2
Kim, D.-S.3
Kim, T.-H.4
Ha, H.-S.5
Kim, W.-Y.6
Park, H.-K.7
Kim, C.-M.8
Kim, H.-S.9
-
69
-
-
84355163093
-
DNA-binding factors shape the mouse methylome at distal regulatory regions
-
doi: 10.1038/nature10716.
-
Stadler MB, Murr R, Burger L, Ivanek R, Lienert F, Schöler A, Wirbelauer C, Oakeley EJ, Gaidatzis D, Tiwari VK, et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 2011, 480:490-495. doi: 10.1038/nature10716.
-
(2011)
Nature
, vol.480
, pp. 490-495
-
-
Stadler, M.B.1
Murr, R.2
Burger, L.3
Ivanek, R.4
Lienert, F.5
Schöler, A.6
Wirbelauer, C.7
Oakeley, E.J.8
Gaidatzis, D.9
Tiwari, V.K.10
-
70
-
-
84865755978
-
The accessible chromatin landscape of the human genome
-
doi: 10.1038/nature11232.
-
Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Haugen E, Sheffield NC, Stergachis AB, Wang H, Vernot B, et al. The accessible chromatin landscape of the human genome. Nature 2012, 489:75-82. doi: 10.1038/nature11232.
-
(2012)
Nature
, vol.489
, pp. 75-82
-
-
Thurman, R.E.1
Rynes, E.2
Humbert, R.3
Vierstra, J.4
Maurano, M.T.5
Haugen, E.6
Sheffield, N.C.7
Stergachis, A.B.8
Wang, H.9
Vernot, B.10
-
71
-
-
73449113904
-
Dnmt3/transcription factor interactions as crucial players in targeted DNa methylation
-
Hervouet E, Vallette FM, Cartron P-F. Dnmt3/transcription factor interactions as crucial players in targeted DNa methylation. Epigenetics 2009, 4:487-499.
-
(2009)
Epigenetics
, vol.4
, pp. 487-499
-
-
Hervouet, E.1
Vallette, F.M.2
Cartron, P.-F.3
-
72
-
-
84863794131
-
The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3
-
doi: 10.4161/cc.20864.
-
Love IM, Sekaric P, Shi D, Grossman SR, Androphy EJ. The histone acetyltransferase PCAF regulates p21 transcription through stress-induced acetylation of histone H3. Cell Cycle 2012, 11:2458-2466. doi: 10.4161/cc.20864.
-
(2012)
Cell Cycle
, vol.11
, pp. 2458-2466
-
-
Love, I.M.1
Sekaric, P.2
Shi, D.3
Grossman, S.R.4
Androphy, E.J.5
-
73
-
-
84873451028
-
Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma
-
doi: 10.1186/1756-9966-32-8.
-
Wang Y, Zhang R, Wu D, Lu Z, Sun W, Cai Y, Wang C, Jin J. Epigenetic change in kidney tumor: downregulation of histone acetyltransferase MYST1 in human renal cell carcinoma. J Exp Clin Cancer Res 2013, 32:8. doi: 10.1186/1756-9966-32-8.
-
(2013)
J Exp Clin Cancer Res
, vol.32
, pp. 8
-
-
Wang, Y.1
Zhang, R.2
Wu, D.3
Lu, Z.4
Sun, W.5
Cai, Y.6
Wang, C.7
Jin, J.8
-
74
-
-
84859458145
-
Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs
-
doi: 10.1038/leu.2011.376.
-
Maiques-Diaz A, Chou FS, Wunderlich M, Gomez-Lopez G, Jacinto FV, Rodriguez-Perales S, Larrayoz MJ, Calasanz MJ, Mulloy JC, Cigudosa JC, et al. Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs. Leukemia 2012, 26:1329-1337. doi: 10.1038/leu.2011.376.
-
(2012)
Leukemia
, vol.26
, pp. 1329-1337
-
-
Maiques-Diaz, A.1
Chou, F.S.2
Wunderlich, M.3
Gomez-Lopez, G.4
Jacinto, F.V.5
Rodriguez-Perales, S.6
Larrayoz, M.J.7
Calasanz, M.J.8
Mulloy, J.C.9
Cigudosa, J.C.10
-
75
-
-
84889263268
-
Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells
-
doi: 10.3390/ijms140611981.
-
Li K, Liu C, Zhou B, Bi L, Huang H, Lin T, Xu K. Role of EZH2 in the growth of prostate cancer stem cells isolated from LNCaP cells. Int J Mol Sci 2013, 14:11981-11993. doi: 10.3390/ijms140611981.
-
(2013)
Int J Mol Sci
, vol.14
, pp. 11981-11993
-
-
Li, K.1
Liu, C.2
Zhou, B.3
Bi, L.4
Huang, H.5
Lin, T.6
Xu, K.7
-
76
-
-
84887322071
-
Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells
-
doi: 10.1038/leu.2013.91.
-
Wei Y, Chen R, Dimicoli S, Bueso-Ramos C, Neuberg D, Pierce S, Wang H, Yang H, Jia Y, Zheng H, et al. Global H3K4me3 genome mapping reveals alterations of innate immunity signaling and overexpression of JMJD3 in human myelodysplastic syndrome CD34+ cells. Leukemia 2013. doi: 10.1038/leu.2013.91.
-
(2013)
Leukemia
-
-
Wei, Y.1
Chen, R.2
Dimicoli, S.3
Bueso-Ramos, C.4
Neuberg, D.5
Pierce, S.6
Wang, H.7
Yang, H.8
Jia, Y.9
Zheng, H.10
-
77
-
-
84862777348
-
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
-
doi: 10.1038/nature10833.
-
Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tonjes M, et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012, 482:226-231. doi: 10.1038/nature10833.
-
(2012)
Nature
, vol.482
, pp. 226-231
-
-
Schwartzentruber, J.1
Korshunov, A.2
Liu, X.Y.3
Jones, D.T.4
Pfaff, E.5
Jacob, K.6
Sturm, D.7
Fontebasso, A.M.8
Quang, D.A.9
Tonjes, M.10
-
78
-
-
84860540565
-
Investigation of the acetylation mechanism by GCN5 histone acetyltransferase
-
Jiang J, Lu J, Lu D, Liang Z, Li L, Ouyang S, Kong X, Jiang H, Shen B, Luo C. Investigation of the acetylation mechanism by GCN5 histone acetyltransferase. PLoS One 2012, 7:e36660.
-
(2012)
PLoS One
, vol.7
-
-
Jiang, J.1
Lu, J.2
Lu, D.3
Liang, Z.4
Li, L.5
Ouyang, S.6
Kong, X.7
Jiang, H.8
Shen, B.9
Luo, C.10
-
79
-
-
0035800524
-
Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor
-
doi: 10.1126/science.1060781.
-
Wang H, Huang ZQ, Xia L, Feng Q, Erdjument-Bromage H, Strahl BD, Briggs SD, Allis CD, Wong J, Tempst P, et al. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 2001, 293:853-857. doi: 10.1126/science.1060781.
-
(2001)
Science
, vol.293
, pp. 853-857
-
-
Wang, H.1
Huang, Z.Q.2
Xia, L.3
Feng, Q.4
Erdjument-Bromage, H.5
Strahl, B.D.6
Briggs, S.D.7
Allis, C.D.8
Wong, J.9
Tempst, P.10
-
80
-
-
84879745132
-
Posttranslational modifications of the histone 3 tail and their impact on the activity of histone lysine demethylases in vitro
-
Lohse B, Helgstrand C, Kristensen JB, Leurs U, Cloos PA, Kristensen JL, Clausen RP. Posttranslational modifications of the histone 3 tail and their impact on the activity of histone lysine demethylases in vitro. PLoS One 2013, 8:e67653.
-
(2013)
PLoS One
, vol.8
-
-
Lohse, B.1
Helgstrand, C.2
Kristensen, J.B.3
Leurs, U.4
Cloos, P.A.5
Kristensen, J.L.6
Clausen, R.P.7
-
81
-
-
84886672166
-
Histone H2A ubiquitination inhibits the enzymatic activity of H3 Lysine 36 methyltransferases
-
doi: 10.1074/jbc.M113.475996.
-
Yuan G, Ma B, Yuan W, Zhang Z, Chen P, Ding X, Feng L, Shen X, Chen S, Li G, et al. Histone H2A ubiquitination inhibits the enzymatic activity of H3 Lysine 36 methyltransferases. J Biol Chem 2013, 288:30832-30842. doi: 10.1074/jbc.M113.475996.
-
(2013)
J Biol Chem
, vol.288
, pp. 30832-30842
-
-
Yuan, G.1
Ma, B.2
Yuan, W.3
Zhang, Z.4
Chen, P.5
Ding, X.6
Feng, L.7
Shen, X.8
Chen, S.9
Li, G.10
-
82
-
-
0344824404
-
Histone sumoylation is associated with transcriptional repression
-
Shiio Y, Eisenman RN. Histone sumoylation is associated with transcriptional repression. Proc Natl Acad Sci USA 2003, 100:13225-13230.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 13225-13230
-
-
Shiio, Y.1
Eisenman, R.N.2
-
83
-
-
33846113751
-
N-formylation of lysine in histone proteins as a secondary modification arising from oxidative DNA damage
-
Jiang T, Zhou X, Taghizadeh K, Dong M, Dedon PC. N-formylation of lysine in histone proteins as a secondary modification arising from oxidative DNA damage. Proc Natl Acad Sci USA 2007, 104:60-65.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 60-65
-
-
Jiang, T.1
Zhou, X.2
Taghizadeh, K.3
Dong, M.4
Dedon, P.C.5
-
84
-
-
84874761632
-
Lysyl 5-Hydroxylation, a Novel Histone Modification, by Jumonji Domain Containing 6 (JMJD6)
-
Unoki M, Masuda A, Dohmae N, Arita K, Yoshimatsu M, Iwai Y, Fukui Y, Ueda K, Hamamoto R, Shirakawa M. Lysyl 5-Hydroxylation, a Novel Histone Modification, by Jumonji Domain Containing 6 (JMJD6). J Biol Chem 2013, 288:6053-6062.
-
(2013)
J Biol Chem
, vol.288
, pp. 6053-6062
-
-
Unoki, M.1
Masuda, A.2
Dohmae, N.3
Arita, K.4
Yoshimatsu, M.5
Iwai, Y.6
Fukui, Y.7
Ueda, K.8
Hamamoto, R.9
Shirakawa, M.10
-
85
-
-
79952534189
-
Regulation of chromatin by histone modifications
-
Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res 2011, 21:381-395.
-
(2011)
Cell Res
, vol.21
, pp. 381-395
-
-
Bannister, A.J.1
Kouzarides, T.2
-
86
-
-
84875149194
-
Regulation of nucleosome dynamics by histone modifications
-
doi: 10.1038/nsmb.2470.
-
Zentner GE, Henikoff S. Regulation of nucleosome dynamics by histone modifications. Nat Struct Mol Biol 2013, 20:259-266. doi: 10.1038/nsmb.2470.
-
(2013)
Nat Struct Mol Biol
, vol.20
, pp. 259-266
-
-
Zentner, G.E.1
Henikoff, S.2
-
87
-
-
78751611793
-
Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation
-
doi: 10.1038/emboj.2010.318.
-
Jin Q, Yu LR, Wang L, Zhang Z, Kasper LH, Lee JE, Wang C, Brindle PK, Dent SY, Ge K. Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J 2011, 30:249-262. doi: 10.1038/emboj.2010.318.
-
(2011)
EMBO J
, vol.30
, pp. 249-262
-
-
Jin, Q.1
Yu, L.R.2
Wang, L.3
Zhang, Z.4
Kasper, L.H.5
Lee, J.E.6
Wang, C.7
Brindle, P.K.8
Dent, S.Y.9
Ge, K.10
-
88
-
-
39649119288
-
The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma
-
doi: 10.1002/ijc.23283.
-
Pfister S, Rea S, Taipale M, Mendrzyk F, Straub B, Ittrich C, Thuerigen O, Sinn HP, Akhtar A, Lichter P. The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma. Int J Cancer 2008, 122:1207-1213. doi: 10.1002/ijc.23283.
-
(2008)
Int J Cancer
, vol.122
, pp. 1207-1213
-
-
Pfister, S.1
Rea, S.2
Taipale, M.3
Mendrzyk, F.4
Straub, B.5
Ittrich, C.6
Thuerigen, O.7
Sinn, H.P.8
Akhtar, A.9
Lichter, P.10
-
89
-
-
84877907026
-
Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression
-
doi: 10.1074/jbc.M113.458737.
-
Chen L, Wei T, Si X, Wang Q, Li Y, Leng Y, Deng A, Chen J, Wang G, Zhu S, et al. Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression. J Biol Chem 2013, 288:14510-14521. doi: 10.1074/jbc.M113.458737.
-
(2013)
J Biol Chem
, vol.288
, pp. 14510-14521
-
-
Chen, L.1
Wei, T.2
Si, X.3
Wang, Q.4
Li, Y.5
Leng, Y.6
Deng, A.7
Chen, J.8
Wang, G.9
Zhu, S.10
-
90
-
-
79952430906
-
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
-
doi: 10.1038/nature09730.
-
Pasqualucci L, Dominguez-Sola D, Chiarenza A, Fabbri G, Grunn A, Trifonov V, Kasper LH, Lerach S, Tang H, Ma J, et al. Inactivating mutations of acetyltransferase genes in B-cell lymphoma. Nature 2011, 471:189-195. doi: 10.1038/nature09730.
-
(2011)
Nature
, vol.471
, pp. 189-195
-
-
Pasqualucci, L.1
Dominguez-Sola, D.2
Chiarenza, A.3
Fabbri, G.4
Grunn, A.5
Trifonov, V.6
Kasper, L.H.7
Lerach, S.8
Tang, H.9
Ma, J.10
-
91
-
-
68349125550
-
Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma
-
doi: 10.1038/onc.2009.137.
-
Zhu C, Qin YR, Xie D, Chua DT, Fung JM, Chen L, Fu L, Hu L, Guan XY. Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma. Oncogene 2009, 28:2821-2828. doi: 10.1038/onc.2009.137.
-
(2009)
Oncogene
, vol.28
, pp. 2821-2828
-
-
Zhu, C.1
Qin, Y.R.2
Xie, D.3
Chua, D.T.4
Fung, J.M.5
Chen, L.6
Fu, L.7
Hu, L.8
Guan, X.Y.9
-
92
-
-
84859004082
-
Elevated level of lysine 9-acetylated histone H3 at the MDR1 promoter in multidrug-resistant cells
-
doi: 10.1111/j.1349-7006.2012.02215.x.
-
Toth M, Boros IM, Balint E. Elevated level of lysine 9-acetylated histone H3 at the MDR1 promoter in multidrug-resistant cells. Cancer Sci 2012, 103:659-669. doi: 10.1111/j.1349-7006.2012.02215.x.
-
(2012)
Cancer Sci
, vol.103
, pp. 659-669
-
-
Toth, M.1
Boros, I.M.2
Balint, E.3
-
93
-
-
84884291890
-
Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells
-
doi: 10.1038/jid.2013.187.
-
Yan G, Eller MS, Elm C, Larocca CA, Ryu B, Panova IP, Dancy BM, Bowers EM, Meyers D, Lareau L, et al. Selective inhibition of p300 HAT blocks cell cycle progression, induces cellular senescence, and inhibits the DNA damage response in melanoma cells. J Invest Dermatol 2013, 133:2444-2452. doi: 10.1038/jid.2013.187.
-
(2013)
J Invest Dermatol
, vol.133
, pp. 2444-2452
-
-
Yan, G.1
Eller, M.S.2
Elm, C.3
Larocca, C.A.4
Ryu, B.5
Panova, I.P.6
Dancy, B.M.7
Bowers, E.M.8
Meyers, D.9
Lareau, L.10
-
94
-
-
84878442601
-
Histone acetyltransferase hMOF promotes S phase entry and tumorigenesis in lung cancer
-
doi: 10.1016/j.cellsig.2013.04.006.
-
Zhao L, Wang DL, Liu Y, Chen S, Sun FL. Histone acetyltransferase hMOF promotes S phase entry and tumorigenesis in lung cancer. Cell Signal 2013, 25:1689-1698. doi: 10.1016/j.cellsig.2013.04.006.
-
(2013)
Cell Signal
, vol.25
, pp. 1689-1698
-
-
Zhao, L.1
Wang, D.L.2
Liu, Y.3
Chen, S.4
Sun, F.L.5
-
95
-
-
84878401588
-
HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure
-
doi: 10.1371/journal.pone.0064600.
-
Stypula-Cyrus Y, Damania D, Kunte DP, Cruz MD, Subramanian H, Roy HK, Backman V. HDAC up-regulation in early colon field carcinogenesis is involved in cell tumorigenicity through regulation of chromatin structure. PLoS One 2013, 8:e64600. doi: 10.1371/journal.pone.0064600.
-
(2013)
PLoS One
, vol.8
-
-
Stypula-Cyrus, Y.1
Damania, D.2
Kunte, D.P.3
Cruz, M.D.4
Subramanian, H.5
Roy, H.K.6
Backman, V.7
-
96
-
-
84859565614
-
HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins
-
doi: 10.1002/jcb.24090.
-
Jung KH, Noh JH, Kim JK, Eun JW, Bae HJ, Xie HJ, Chang YG, Kim MG, Park H, Lee JY, et al. HDAC2 overexpression confers oncogenic potential to human lung cancer cells by deregulating expression of apoptosis and cell cycle proteins. J Cell Biochem 2012, 113:2167-2177. doi: 10.1002/jcb.24090.
-
(2012)
J Cell Biochem
, vol.113
, pp. 2167-2177
-
-
Jung, K.H.1
Noh, J.H.2
Kim, J.K.3
Eun, J.W.4
Bae, H.J.5
Xie, H.J.6
Chang, Y.G.7
Kim, M.G.8
Park, H.9
Lee, J.Y.10
-
97
-
-
78149468828
-
Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects
-
doi: 10.1038/onc.2010.332.
-
Marshall GM, Gherardi S, Xu N, Neiron Z, Trahair T, Scarlett CJ, Chang DK, Liu PY, Jankowski K, Iraci N, et al. Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects. Oncogene 2010, 29:5957-5968. doi: 10.1038/onc.2010.332.
-
(2010)
Oncogene
, vol.29
, pp. 5957-5968
-
-
Marshall, G.M.1
Gherardi, S.2
Xu, N.3
Neiron, Z.4
Trahair, T.5
Scarlett, C.J.6
Chang, D.K.7
Liu, P.Y.8
Jankowski, K.9
Iraci, N.10
-
98
-
-
84862541934
-
Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer
-
doi: 10.1007/s00109-011-0837-0.
-
Rodriguez RM, Huidobro C, Urdinguio RG, Mangas C, Soldevilla B, Dominguez G, Bonilla F, Fernandez AF, Fraga MF. Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer. J Mol Med (Berl) 2012, 90:587-595. doi: 10.1007/s00109-011-0837-0.
-
(2012)
J Mol Med (Berl)
, vol.90
, pp. 587-595
-
-
Rodriguez, R.M.1
Huidobro, C.2
Urdinguio, R.G.3
Mangas, C.4
Soldevilla, B.5
Dominguez, G.6
Bonilla, F.7
Fernandez, A.F.8
Fraga, M.F.9
-
99
-
-
84857195696
-
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia
-
doi: 10.1038/nchembio.773.
-
Grembecka J, He S, Shi A, Purohit T, Muntean AG, Sorenson RJ, Showalter HD, Murai MJ, Belcher AM, Hartley T, et al. Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia. Nat Chem Biol 2012, 8:277-284. doi: 10.1038/nchembio.773.
-
(2012)
Nat Chem Biol
, vol.8
, pp. 277-284
-
-
Grembecka, J.1
He, S.2
Shi, A.3
Purohit, T.4
Muntean, A.G.5
Sorenson, R.J.6
Showalter, H.D.7
Murai, M.J.8
Belcher, A.M.9
Hartley, T.10
-
100
-
-
84878905626
-
Impairing MLL-fusion gene-mediated transformation by dissecting critical interactions with the lens epithelium-derived growth factor (LEDGF/p75)
-
doi: 10.1038/leu.2013.10.
-
Mereau H, De Rijck J, Cermakova K, Kutz A, Juge S, Demeulemeester J, Gijsbers R, Christ F, Debyser Z, Schwaller J. Impairing MLL-fusion gene-mediated transformation by dissecting critical interactions with the lens epithelium-derived growth factor (LEDGF/p75). Leukemia 2013, 27:1245-1253. doi: 10.1038/leu.2013.10.
-
(2013)
Leukemia
, vol.27
, pp. 1245-1253
-
-
Mereau, H.1
De Rijck, J.2
Cermakova, K.3
Kutz, A.4
Juge, S.5
Demeulemeester, J.6
Gijsbers, R.7
Christ, F.8
Debyser, Z.9
Schwaller, J.10
-
101
-
-
76549105779
-
MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele
-
doi: 10.1016/j.ccr.2009.12.034.
-
Thiel AT, Blessington P, Zou T, Feather D, Wu X, Yan J, Zhang H, Liu Z, Ernst P, Koretzky GA, et al. MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele. Cancer Cell 2010, 17:148-159. doi: 10.1016/j.ccr.2009.12.034.
-
(2010)
Cancer Cell
, vol.17
, pp. 148-159
-
-
Thiel, A.T.1
Blessington, P.2
Zou, T.3
Feather, D.4
Wu, X.5
Yan, J.6
Zhang, H.7
Liu, Z.8
Ernst, P.9
Koretzky, G.A.10
-
102
-
-
84876143288
-
Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l
-
doi: 10.1038/leu.2012.327.
-
Chen L, Deshpande AJ, Banka D, Bernt KM, Dias S, Buske C, Olhava EJ, Daigle SR, Richon VM, Pollock RM, et al. Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l. Leukemia 2013, 27:813-822. doi: 10.1038/leu.2012.327.
-
(2013)
Leukemia
, vol.27
, pp. 813-822
-
-
Chen, L.1
Deshpande, A.J.2
Banka, D.3
Bernt, K.M.4
Dias, S.5
Buske, C.6
Olhava, E.J.7
Daigle, S.R.8
Richon, V.M.9
Pollock, R.M.10
-
103
-
-
84870573126
-
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
-
doi: 10.1038/nature11606.
-
McCabe MT, Ott HM, Ganji G, Korenchuk S, Thompson C, Van Aller GS, Liu Y, Graves AP, Della Pietra A 3, Diaz E, et al. EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations. Nature 2012, 492:108-112. doi: 10.1038/nature11606.
-
(2012)
Nature
, vol.492
, pp. 108-112
-
-
McCabe, M.T.1
Ott, H.M.2
Ganji, G.3
Korenchuk, S.4
Thompson, C.5
Van Aller, G.S.6
Liu, Y.7
Graves, A.P.8
Della Pietra III, A.9
Diaz, E.10
-
104
-
-
84878921669
-
Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies
-
doi: 10.1038/leu.2013.80.
-
Khan SN, Jankowska AM, Mahfouz R, Dunbar AJ, Sugimoto Y, Hosono N, Hu Z, Cheriyath V, Vatolin S, Przychodzen B, et al. Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies. Leukemia 2013, 27:1301-1309. doi: 10.1038/leu.2013.80.
-
(2013)
Leukemia
, vol.27
, pp. 1301-1309
-
-
Khan, S.N.1
Jankowska, A.M.2
Mahfouz, R.3
Dunbar, A.J.4
Sugimoto, Y.5
Hosono, N.6
Hu, Z.7
Cheriyath, V.8
Vatolin, S.9
Przychodzen, B.10
-
105
-
-
84863165348
-
Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)
-
doi: 10.1073/pnas.1116418109.
-
McCabe MT, Graves AP, Ganji G, Diaz E, Halsey WS, Jiang Y, Smitheman KN, Ott HM, Pappalardi MB, Allen KE, et al. Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27). Proc Natl Acad Sci USA 2012, 109:2989-2994. doi: 10.1073/pnas.1116418109.
-
(2012)
Proc Natl Acad Sci USA
, vol.109
, pp. 2989-2994
-
-
McCabe, M.T.1
Graves, A.P.2
Ganji, G.3
Diaz, E.4
Halsey, W.S.5
Jiang, Y.6
Smitheman, K.N.7
Ott, H.M.8
Pappalardi, M.B.9
Allen, K.E.10
-
106
-
-
84867401194
-
Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells
-
doi: 10.1016/j.lungcan.2012.08.003.
-
Kikuchi J, Takashina T, Kinoshita I, Kikuchi E, Shimizu Y, Sakakibara-Konishi J, Oizumi S, Marquez VE, Nishimura M, Dosaka-Akita H. Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. Lung Cancer 2012, 78:138-143. doi: 10.1016/j.lungcan.2012.08.003.
-
(2012)
Lung Cancer
, vol.78
, pp. 138-143
-
-
Kikuchi, J.1
Takashina, T.2
Kinoshita, I.3
Kikuchi, E.4
Shimizu, Y.5
Sakakibara-Konishi, J.6
Oizumi, S.7
Marquez, V.E.8
Nishimura, M.9
Dosaka-Akita, H.10
-
107
-
-
44249128891
-
Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells
-
doi: 10.1371/journal.pone.0002037.
-
Kondo Y, Shen L, Ahmed S, Boumber Y, Sekido Y, Haddad BR, Issa JP. Downregulation of histone H3 lysine 9 methyltransferase G9a induces centrosome disruption and chromosome instability in cancer cells. PLoS One 2008, 3:e2037. doi: 10.1371/journal.pone.0002037.
-
(2008)
PLoS One
, vol.3
-
-
Kondo, Y.1
Shen, L.2
Ahmed, S.3
Boumber, Y.4
Sekido, Y.5
Haddad, B.R.6
Issa, J.P.7
-
108
-
-
34347392874
-
NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis
-
doi: 10.1038/ncb1608.
-
Wang GG, Cai L, Pasillas MP, Kamps MP. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol 2007, 9:804-812. doi: 10.1038/ncb1608.
-
(2007)
Nat Cell Biol
, vol.9
, pp. 804-812
-
-
Wang, G.G.1
Cai, L.2
Pasillas, M.P.3
Kamps, M.P.4
-
109
-
-
68749108259
-
LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer
-
doi: 10.1016/j.cell.2009.05.050.
-
Wang Y, Zhang H, Chen Y, Sun Y, Yang F, Yu W, Liang J, Sun L, Yang X, Shi L, et al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell 2009, 138:660-672. doi: 10.1016/j.cell.2009.05.050.
-
(2009)
Cell
, vol.138
, pp. 660-672
-
-
Wang, Y.1
Zhang, H.2
Chen, Y.3
Sun, Y.4
Yang, F.5
Yu, W.6
Liang, J.7
Sun, L.8
Yang, X.9
Shi, L.10
-
110
-
-
84862777766
-
Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
-
doi: 10.1038/nm.2661.
-
Schenk T, Chen WC, Gollner S, Howell L, Jin L, Hebestreit K, Klein HU, Popescu AC, Burnett A, Mills K, et al. Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia. Nat Med 2012, 18:605-611. doi: 10.1038/nm.2661.
-
(2012)
Nat Med
, vol.18
, pp. 605-611
-
-
Schenk, T.1
Chen, W.C.2
Gollner, S.3
Howell, L.4
Jin, L.5
Hebestreit, K.6
Klein, H.U.7
Popescu, A.C.8
Burnett, A.9
Mills, K.10
-
111
-
-
84890434451
-
NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern
-
doi: 10.1038/leu.2013.87.
-
de Rooij JD, Hollink IH, Arentsen-Peters ST, van Galen JF, Berna Beverloo H, Baruchel A, Trka J, Reinhardt D, Sonneveld E, Zimmermann M, et al. NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. Leukemia 2013. doi: 10.1038/leu.2013.87.
-
(2013)
Leukemia
-
-
de Rooij, J.D.1
Hollink, I.H.2
Arentsen-Peters, S.T.3
van Galen, J.F.4
Berna Beverloo, H.5
Baruchel, A.6
Trka, J.7
Reinhardt, D.8
Sonneveld, E.9
Zimmermann, M.10
-
112
-
-
75149188170
-
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
-
doi: 10.1038/nature08672.
-
Dalgliesh GL, Furge K, Greenman C, Chen L, Bignell G, Butler A, Davies H, Edkins S, Hardy C, Latimer C, et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 2010, 463:360-363. doi: 10.1038/nature08672.
-
(2010)
Nature
, vol.463
, pp. 360-363
-
-
Dalgliesh, G.L.1
Furge, K.2
Greenman, C.3
Chen, L.4
Bignell, G.5
Butler, A.6
Davies, H.7
Edkins, S.8
Hardy, C.9
Latimer, C.10
-
113
-
-
84856955226
-
The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C
-
doi: 10.1038/onc.2011.266.
-
Niu X, Zhang T, Liao L, Zhou L, Lindner DJ, Zhou M, Rini B, Yan Q, Yang H. The von Hippel-Lindau tumor suppressor protein regulates gene expression and tumor growth through histone demethylase JARID1C. Oncogene 2012, 31:776-786. doi: 10.1038/onc.2011.266.
-
(2012)
Oncogene
, vol.31
, pp. 776-786
-
-
Niu, X.1
Zhang, T.2
Liao, L.3
Zhou, L.4
Lindner, D.J.5
Zhou, M.6
Rini, B.7
Yan, Q.8
Yang, H.9
-
114
-
-
84877616497
-
Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis
-
ra28 1-13, S0-15. doi: 10.1126/scisignal.2003884.
-
Ding X, Pan H, Li J, Zhong Q, Chen X, Dry SM, Wang CY. Epigenetic activation of AP1 promotes squamous cell carcinoma metastasis. Sci Signal 2013, 6 ra28 1-13, S0-15. doi: 10.1126/scisignal.2003884.
-
(2013)
Sci Signal
, vol.6
-
-
Ding, X.1
Pan, H.2
Li, J.3
Zhong, Q.4
Chen, X.5
Dry, S.M.6
Wang, C.Y.7
-
115
-
-
67349203626
-
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
-
doi: 10.1038/ng.349.
-
van Haaften G, Dalgliesh GL, Davies H, Chen L, Bignell G, Greenman C, Edkins S, Hardy C, O'Meara S, Teague J, et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nat Genet 2009, 41:521-523. doi: 10.1038/ng.349.
-
(2009)
Nat Genet
, vol.41
, pp. 521-523
-
-
van Haaften, G.1
Dalgliesh, G.L.2
Davies, H.3
Chen, L.4
Bignell, G.5
Greenman, C.6
Edkins, S.7
Hardy, C.8
O'Meara, S.9
Teague, J.10
-
116
-
-
67349266612
-
Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger
-
doi: 10.1038/nature08036.
-
Wang GG, Song J, Wang Z, Dormann HL, Casadio F, Li H, Luo JL, Patel DJ, Allis CD. Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger. Nature 2009, 459:847-851. doi: 10.1038/nature08036.
-
(2009)
Nature
, vol.459
, pp. 847-851
-
-
Wang, G.G.1
Song, J.2
Wang, Z.3
Dormann, H.L.4
Casadio, F.5
Li, H.6
Luo, J.L.7
Patel, D.J.8
Allis, C.D.9
-
117
-
-
67449104554
-
ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression
-
doi: 10.1002/ijc.24437.
-
Kumamoto K, Fujita K, Kurotani R, Saito M, Unoki M, Hagiwara N, Shiga H, Bowman ED, Yanaihara N, Okamura S, et al. ING2 is upregulated in colon cancer and increases invasion by enhanced MMP13 expression. Int J Cancer 2009, 125:1306-1315. doi: 10.1002/ijc.24437.
-
(2009)
Int J Cancer
, vol.125
, pp. 1306-1315
-
-
Kumamoto, K.1
Fujita, K.2
Kurotani, R.3
Saito, M.4
Unoki, M.5
Hagiwara, N.6
Shiga, H.7
Bowman, E.D.8
Yanaihara, N.9
Okamura, S.10
-
118
-
-
84874265490
-
Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma
-
doi: 10.1371/journal.pone.0055820.
-
Proctor E, Waghray M, Lee CJ, Heidt DG, Yalamanchili M, Li C, Bednar F, Simeone DM. Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma. PLoS One 2013, 8:e55820. doi: 10.1371/journal.pone.0055820.
-
(2013)
PLoS One
, vol.8
-
-
Proctor, E.1
Waghray, M.2
Lee, C.J.3
Heidt, D.G.4
Yalamanchili, M.5
Li, C.6
Bednar, F.7
Simeone, D.M.8
-
119
-
-
78650758676
-
Histone H3K27ac separates active from poised enhancers and predicts developmental state
-
Creyghton MP, Cheng AW, Welstead GG, Kooistra T, Carey BW, Steine EJ, Hanna J, Lodato MA, Frampton GM, Sharp PA. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc Natl Acad Sci USA 2010, 107:21931-21936.
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 21931-21936
-
-
Creyghton, M.P.1
Cheng, A.W.2
Welstead, G.G.3
Kooistra, T.4
Carey, B.W.5
Steine, E.J.6
Hanna, J.7
Lodato, M.A.8
Frampton, G.M.9
Sharp, P.A.10
-
120
-
-
84860841594
-
Epigenomic enhancer profiling defines a signature of colon cancer
-
Akhtar-Zaidi B, Cowper-Sal R, Corradin O, Saiakhova A, Bartels CF, Balasubramanian D, Myeroff L, Lutterbaugh J, Jarrar A, Kalady MF. Epigenomic enhancer profiling defines a signature of colon cancer. Science 2012, 336:736-739.
-
(2012)
Science
, vol.336
, pp. 736-739
-
-
Akhtar-Zaidi, B.1
Cowper-Sal, R.2
Corradin, O.3
Saiakhova, A.4
Bartels, C.F.5
Balasubramanian, D.6
Myeroff, L.7
Lutterbaugh, J.8
Jarrar, A.9
Kalady, M.F.10
-
121
-
-
79959198166
-
Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA
-
Wang D, Garcia-Bassets I, Benner C, Li W, Su X, Zhou Y, Qiu J, Liu W, Kaikkonen MU, Ohgi KA. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature 2011, 474:390-394.
-
(2011)
Nature
, vol.474
, pp. 390-394
-
-
Wang, D.1
Garcia-Bassets, I.2
Benner, C.3
Li, W.4
Su, X.5
Zhou, Y.6
Qiu, J.7
Liu, W.8
Kaikkonen, M.U.9
Ohgi, K.A.10
-
122
-
-
82955247831
-
Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes
-
Lombardi PM, Cole KE, Dowling DP, Christianson DW. Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes. Curr Opin Struct Biol 2011, 21:735-743.
-
(2011)
Curr Opin Struct Biol
, vol.21
, pp. 735-743
-
-
Lombardi, P.M.1
Cole, K.E.2
Dowling, D.P.3
Christianson, D.W.4
-
123
-
-
0036830642
-
Role of histone H3 lysine 27 methylation in Polycomb-group silencing
-
Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, Tempst P, Jones RS, Zhang Y. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 2002, 298:1039-1043.
-
(2002)
Science
, vol.298
, pp. 1039-1043
-
-
Cao, R.1
Wang, L.2
Wang, H.3
Xia, L.4
Erdjument-Bromage, H.5
Tempst, P.6
Jones, R.S.7
Zhang, Y.8
-
124
-
-
34547433238
-
Mechanism of histone methylation catalyzed by protein lysine methyltransferase SET7/9 and origin of product specificity
-
Guo H-B, Guo H. Mechanism of histone methylation catalyzed by protein lysine methyltransferase SET7/9 and origin of product specificity. Proc Natl Acad Sci USA 2007, 104:8797-8802.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 8797-8802
-
-
Guo, H.-B.1
Guo, H.2
-
125
-
-
77951539195
-
Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon
-
doi: 10.1186/1475-2867-10-13.
-
Natarajan TG, Kallakury BV, Sheehan CE, Bartlett MB, Ganesan N, Preet A, Ross JS, Fitzgerald KT. Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon. Cancer Cell Int 2010, 10:13. doi: 10.1186/1475-2867-10-13.
-
(2010)
Cancer Cell Int
, vol.10
, pp. 13
-
-
Natarajan, T.G.1
Kallakury, B.V.2
Sheehan, C.E.3
Bartlett, M.B.4
Ganesan, N.5
Preet, A.6
Ross, J.S.7
Fitzgerald, K.T.8
-
126
-
-
80052269038
-
Analysis of the coding genome of diffuse large B-cell lymphoma
-
doi: 10.1038/ng.892.
-
Pasqualucci L, Trifonov V, Fabbri G, Ma J, Rossi D, Chiarenza A, Wells VA, Grunn A, Messina M, Elliot O, et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011, 43:830. doi: 10.1038/ng.892.
-
(2011)
Nat Genet
, vol.43
, pp. 830
-
-
Pasqualucci, L.1
Trifonov, V.2
Fabbri, G.3
Ma, J.4
Rossi, D.5
Chiarenza, A.6
Wells, V.A.7
Grunn, A.8
Messina, M.9
Elliot, O.10
-
127
-
-
58949087354
-
MMSET is overexpressed in cancers: link with tumor aggressiveness
-
Kassambara A, Klein B, Moreaux J. MMSET is overexpressed in cancers: link with tumor aggressiveness. Biochem Biophys Res Commun 2009, 379:840-845.
-
(2009)
Biochem Biophys Res Commun
, vol.379
, pp. 840-845
-
-
Kassambara, A.1
Klein, B.2
Moreaux, J.3
-
128
-
-
79955506975
-
The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors
-
Hudlebusch HR, Santoni-Rugiu E, Simon R, Ralfkiær E, Rossing HH, Johansen JV, Jørgensen M, Sauter G, Helin K. The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors. Clin Cancer Res 2011, 17:2919-2933.
-
(2011)
Clin Cancer Res
, vol.17
, pp. 2919-2933
-
-
Hudlebusch, H.R.1
Santoni-Rugiu, E.2
Simon, R.3
Ralfkiær, E.4
Rossing, H.H.5
Johansen, J.V.6
Jørgensen, M.7
Sauter, G.8
Helin, K.9
-
129
-
-
78049307486
-
H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM
-
doi: 10.1158/0008-5472.CAN-10-0833.
-
Chen MW, Hua KT, Kao HJ, Chi CC, Wei LH, Johansson G, Shiah SG, Chen PS, Jeng YM, Cheng TY, et al. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. Cancer Res 2010, 70:7830-7840. doi: 10.1158/0008-5472.CAN-10-0833.
-
(2010)
Cancer Res
, vol.70
, pp. 7830-7840
-
-
Chen, M.W.1
Hua, K.T.2
Kao, H.J.3
Chi, C.C.4
Wei, L.H.5
Johansson, G.6
Shiah, S.G.7
Chen, P.S.8
Jeng, Y.M.9
Cheng, T.Y.10
-
130
-
-
84890377101
-
The role of G9a in tumorigenesis in head and neck cancer
-
doi: 10.1177/0194599812451426a184.
-
Tan C-T, Ko J-Y, Tsai H-H. The role of G9a in tumorigenesis in head and neck cancer. Otolaryngol Head Neck Surg 2012, 147:P183-P184. doi: 10.1177/0194599812451426a184.
-
(2012)
Otolaryngol Head Neck Surg
, vol.147
-
-
Tan, C.-T.1
Ko, J.-Y.2
Tsai, H.-H.3
-
131
-
-
84877923461
-
NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia
-
doi: 10.1002/gcc.22064.
-
Shiba N, Ichikawa H, Taki T, Park MJ, Jo A, Mitani S, Kobayashi T, Shimada A, Sotomatsu M, Arakawa H, et al. NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia. Genes Chromosomes Cancer 2013, 52:683-693. doi: 10.1002/gcc.22064.
-
(2013)
Genes Chromosomes Cancer
, vol.52
, pp. 683-693
-
-
Shiba, N.1
Ichikawa, H.2
Taki, T.3
Park, M.J.4
Jo, A.5
Mitani, S.6
Kobayashi, T.7
Shimada, A.8
Sotomatsu, M.9
Arakawa, H.10
-
132
-
-
82655179979
-
Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties
-
doi: 10.1158/0008-5472.CAN-11-0896.
-
Wang J, Lu F, Ren Q, Sun H, Xu Z, Lan R, Liu Y, Ward D, Quan J, Ye T, et al. Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties. Cancer Res 2011, 71:7238-7249. doi: 10.1158/0008-5472.CAN-11-0896.
-
(2011)
Cancer Res
, vol.71
, pp. 7238-7249
-
-
Wang, J.1
Lu, F.2
Ren, Q.3
Sun, H.4
Xu, Z.5
Lan, R.6
Liu, Y.7
Ward, D.8
Quan, J.9
Ye, T.10
-
133
-
-
84877855147
-
Inhibition of histone demethylase JMJD1A improves anti-angiogenic therapy and reduces tumor-associated macrophages
-
doi: 10.1158/0008-5472.CAN-12-3231.
-
Osawa T, Tsuchida R, Muramatsu M, Shimamura T, Wang F, Suehiro J-I, Kanki Y, Wada Y, Yuasa Y, Aburatani H, et al. Inhibition of histone demethylase JMJD1A improves anti-angiogenic therapy and reduces tumor-associated macrophages. Cancer Res 2013, 73:3019-3028. doi: 10.1158/0008-5472.CAN-12-3231.
-
(2013)
Cancer Res
, vol.73
, pp. 3019-3028
-
-
Osawa, T.1
Tsuchida, R.2
Muramatsu, M.3
Shimamura, T.4
Wang, F.5
Suehiro, J.-I.6
Kanki, Y.7
Wada, Y.8
Yuasa, Y.9
Aburatani, H.10
-
134
-
-
84858796262
-
IDH mutation impairs histone demethylation and results in a block to cell differentiation
-
doi: 10.1038/nature10860.
-
Lu C, Ward PS, Kapoor GS, Rohle D, Turcan S, Abdel-Wahab O, Edwards CR, Khanin R, Figueroa ME, Melnick A, et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 2012, 483:474-478. doi: 10.1038/nature10860.
-
(2012)
Nature
, vol.483
, pp. 474-478
-
-
Lu, C.1
Ward, P.S.2
Kapoor, G.S.3
Rohle, D.4
Turcan, S.5
Abdel-Wahab, O.6
Edwards, C.R.7
Khanin, R.8
Figueroa, M.E.9
Melnick, A.10
-
135
-
-
79955547561
-
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
-
doi: 10.1038/embor.2011.43.
-
Chowdhury R, Yeoh KK, Tian YM, Hillringhaus L, Bagg EA, Rose NR, Leung IK, Li XS, Woon EC, Yang M, et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep 2011, 12:463-469. doi: 10.1038/embor.2011.43.
-
(2011)
EMBO Rep
, vol.12
, pp. 463-469
-
-
Chowdhury, R.1
Yeoh, K.K.2
Tian, Y.M.3
Hillringhaus, L.4
Bagg, E.A.5
Rose, N.R.6
Leung, I.K.7
Li, X.S.8
Woon, E.C.9
Yang, M.10
-
136
-
-
77956282774
-
Opposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cells
-
doi: 10.1182/blood-2009-12-260760.
-
Majewski IJ, Ritchie ME, Phipson B, Corbin J, Pakusch M, Ebert A, Busslinger M, Koseki H, Hu Y, Smyth GK, et al. Opposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cells. Blood 2010, 116:731-739. doi: 10.1182/blood-2009-12-260760.
-
(2010)
Blood
, vol.116
, pp. 731-739
-
-
Majewski, I.J.1
Ritchie, M.E.2
Phipson, B.3
Corbin, J.4
Pakusch, M.5
Ebert, A.6
Busslinger, M.7
Koseki, H.8
Hu, Y.9
Smyth, G.K.10
-
137
-
-
33947410413
-
A novel NUP98-PHF23 fusion resulting from a cryptic translocation t(11;17)(p15;p13) in acute myeloid leukemia
-
doi: 10.1038/sj.leu.2404579.
-
Reader JC, Meekins JS, Gojo I, Ning Y. A novel NUP98-PHF23 fusion resulting from a cryptic translocation t(11;17)(p15;p13) in acute myeloid leukemia. Leukemia 2007, 21:842-844. doi: 10.1038/sj.leu.2404579.
-
(2007)
Leukemia
, vol.21
, pp. 842-844
-
-
Reader, J.C.1
Meekins, J.S.2
Gojo, I.3
Ning, Y.4
-
138
-
-
79952197153
-
Histone variant H2A.Z can serve as a new target for breast cancer therapy
-
Rangasamy D. Histone variant H2A.Z can serve as a new target for breast cancer therapy. Curr Med Chem 2010, 17:3155-3161.
-
(2010)
Curr Med Chem
, vol.17
, pp. 3155-3161
-
-
Rangasamy, D.1
-
139
-
-
74949122714
-
H2A.Z overexpression promotes cellular proliferation of breast cancer cells
-
Svotelis A, Gevry N, Grondin G, Gaudreau L. H2A.Z overexpression promotes cellular proliferation of breast cancer cells. Cell Cycle 2010, 9:364-370.
-
(2010)
Cell Cycle
, vol.9
, pp. 364-370
-
-
Svotelis, A.1
Gevry, N.2
Grondin, G.3
Gaudreau, L.4
-
140
-
-
38149028414
-
Copy number alterations of the H2AFX gene in sporadic breast cancer patients
-
doi: 10.1016/j.cancergencyto.2007.09.024.
-
Srivastava N, Gochhait S, Gupta P, Bamezai RN. Copy number alterations of the H2AFX gene in sporadic breast cancer patients. Cancer Genet Cytogenet 2008, 180:121-128. doi: 10.1016/j.cancergencyto.2007.09.024.
-
(2008)
Cancer Genet Cytogenet
, vol.180
, pp. 121-128
-
-
Srivastava, N.1
Gochhait, S.2
Gupta, P.3
Bamezai, R.N.4
-
141
-
-
78650816688
-
The histone variant macroH2A suppresses melanoma progression through regulation of CDK8
-
doi: 10.1038/nature09590.
-
Kapoor A, Goldberg MS, Cumberland LK, Ratnakumar K, Segura MF, Emanuel PO, Menendez S, Vardabasso C, Leroy G, Vidal CI, et al. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature 2010, 468:1105-1109. doi: 10.1038/nature09590.
-
(2010)
Nature
, vol.468
, pp. 1105-1109
-
-
Kapoor, A.1
Goldberg, M.S.2
Cumberland, L.K.3
Ratnakumar, K.4
Segura, M.F.5
Emanuel, P.O.6
Menendez, S.7
Vardabasso, C.8
Leroy, G.9
Vidal, C.I.10
-
142
-
-
84862777410
-
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
-
doi: 10.1038/ng.1102.
-
Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 2012, 44:251-253. doi: 10.1038/ng.1102.
-
(2012)
Nat Genet
, vol.44
, pp. 251-253
-
-
Wu, G.1
Broniscer, A.2
McEachron, T.A.3
Lu, C.4
Paugh, B.S.5
Becksfort, J.6
Qu, C.7
Ding, L.8
Huether, R.9
Parker, M.10
-
143
-
-
84877785024
-
Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma
-
doi: 10.1126/science.1232245.
-
Lewis PW, Muller MM, Koletsky MS, Cordero F, Lin S, Banaszynski LA, Garcia BA, Muir TW, Becher OJ, Allis CD. Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 2013, 340:857-861. doi: 10.1126/science.1232245.
-
(2013)
Science
, vol.340
, pp. 857-861
-
-
Lewis, P.W.1
Muller, M.M.2
Koletsky, M.S.3
Cordero, F.4
Lin, S.5
Banaszynski, L.A.6
Garcia, B.A.7
Muir, T.W.8
Becher, O.J.9
Allis, C.D.10
-
144
-
-
84881479502
-
Genome-wide transcriptional analysis of apoptosis-related genes and pathways regulated by H2AX in lung cancer A549 cells
-
doi: 10.1007/s10495-013-0875-x.
-
Lu C, Xiong M, Luo Y, Li J, Zhang Y, Dong Y, Zhu Y, Niu T, Wang Z, Duan L. Genome-wide transcriptional analysis of apoptosis-related genes and pathways regulated by H2AX in lung cancer A549 cells. Apoptosis 2013, 18:1039-1047. doi: 10.1007/s10495-013-0875-x.
-
(2013)
Apoptosis
, vol.18
, pp. 1039-1047
-
-
Lu, C.1
Xiong, M.2
Luo, Y.3
Li, J.4
Zhang, Y.5
Dong, Y.6
Zhu, Y.7
Niu, T.8
Wang, Z.9
Duan, L.10
-
145
-
-
42149103735
-
Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression
-
doi: 10.1038/msb.2008.25.
-
Hua S, Kallen CB, Dhar R, Baquero MT, Mason CE, Russell BA, Shah PK, Liu J, Khramtsov A, Tretiakova MS, et al. Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol Syst Biol 2008, 4:188. doi: 10.1038/msb.2008.25.
-
(2008)
Mol Syst Biol
, vol.4
, pp. 188
-
-
Hua, S.1
Kallen, C.B.2
Dhar, R.3
Baquero, M.T.4
Mason, C.E.5
Russell, B.A.6
Shah, P.K.7
Liu, J.8
Khramtsov, A.9
Tretiakova, M.S.10
-
146
-
-
0036782706
-
Transcription factors as targets for cancer therapy
-
doi: 10.1038/nrc906.
-
Darnell JE. Transcription factors as targets for cancer therapy. Nat Rev Cancer 2002, 2:740-749. doi: 10.1038/nrc906.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 740-749
-
-
Darnell, J.E.1
-
147
-
-
84874111393
-
Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma
-
doi: 10.1002/ijc.27900.
-
Manceau G, Letouzé E, Guichard C, Didelot A, Cazes A, Corté H, Fabre E, Pallier K, Imbeaud S, Le Pimpec-Barthes F, et al. Recurrent inactivating mutations of ARID2 in non-small cell lung carcinoma. Int J Cancer 2013, 132:2217-2221. doi: 10.1002/ijc.27900.
-
(2013)
Int J Cancer
, vol.132
, pp. 2217-2221
-
-
Manceau, G.1
Letouzé, E.2
Guichard, C.3
Didelot, A.4
Cazes, A.5
Corté, H.6
Fabre, E.7
Pallier, K.8
Imbeaud, S.9
Le Pimpec-Barthes, F.10
-
148
-
-
20144389099
-
Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer
-
doi: doi:10.1038/ng1528.
-
Sun X, Frierson HF, Chen C, Li C, Ran Q, Otto KB, Cantarel BM, Vessella RL, Gao AC, Petros J, et al. Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer. Nat Genet 2005, 37:407. doi: doi:10.1038/ng1528.
-
(2005)
Nat Genet
, vol.37
, pp. 407
-
-
Sun, X.1
Frierson, H.F.2
Chen, C.3
Li, C.4
Ran, Q.5
Otto, K.B.6
Cantarel, B.M.7
Vessella, R.L.8
Gao, A.C.9
Petros, J.10
-
149
-
-
34547655924
-
Genetic alterations of the ATBF1 gene in gastric cancer
-
doi: 10.1158/1078-0432.CCR-07-0619.
-
Cho YG, Song JH, Kim CJ, Lee YS, Kim SY, Nam SW, Lee JY, Park WS. Genetic alterations of the ATBF1 gene in gastric cancer. Clin Cancer Res 2007, 13:4355-4359. doi: 10.1158/1078-0432.CCR-07-0619.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 4355-4359
-
-
Cho, Y.G.1
Song, J.H.2
Kim, C.J.3
Lee, Y.S.4
Kim, S.Y.5
Nam, S.W.6
Lee, J.Y.7
Park, W.S.8
-
150
-
-
41149083903
-
Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma
-
doi: 10.1111/j.1365-2559.2008.02980.x.
-
Kim J, Song H, Cho G, Cao Z, Lee S, Nam W, Lee Y, Park S. Down-regulation of ATBF1 is a major inactivating mechanism in hepatocellular carcinoma. Histopathology 2008, 52:552-559. doi: 10.1111/j.1365-2559.2008.02980.x.
-
(2008)
Histopathology
, vol.52
, pp. 552-559
-
-
Kim, J.1
Song, H.2
Cho, G.3
Cao, Z.4
Lee, S.5
Nam, W.6
Lee, Y.7
Park, S.8
-
151
-
-
58349118904
-
Transcription factors: their potential as targets for an individualized therapeutic approach to cancer
-
doi: 10.1038/cgt.2008.73.
-
Mees C, Nemunaitis J, Senzer N. Transcription factors: their potential as targets for an individualized therapeutic approach to cancer. Cancer Gene Ther 2009, 16:103-112. doi: 10.1038/cgt.2008.73.
-
(2009)
Cancer Gene Ther
, vol.16
, pp. 103-112
-
-
Mees, C.1
Nemunaitis, J.2
Senzer, N.3
-
152
-
-
0037082508
-
Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein α in myelodysplastic syndromes and acute myeloid leukemias
-
doi: 10.1182/blood.V99.4.1332.
-
Gombart AF, Hofmann W-K, Kawano S, Takeuchi S, Krug U, Kwok SH, Larsen RJ, Asou H, Miller CW, Hoelzer D, et al. Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein α in myelodysplastic syndromes and acute myeloid leukemias. Blood 2002, 99:1332-1340. doi: 10.1182/blood.V99.4.1332.
-
(2002)
Blood
, vol.99
, pp. 1332-1340
-
-
Gombart, A.F.1
Hofmann, W.-K.2
Kawano, S.3
Takeuchi, S.4
Krug, U.5
Kwok, S.H.6
Larsen, R.J.7
Asou, H.8
Miller, C.W.9
Hoelzer, D.10
-
153
-
-
84862523863
-
Sequence analysis of mutations and translocations across breast cancer subtypes
-
doi: 10.1038/nature11154.
-
Banerji S, Cibulskis K, Rangel-Escareno C, Brown KK, Carter SL, Frederick AM, Lawrence MS, Sivachenko AY, Sougnez C, Zou L, et al. Sequence analysis of mutations and translocations across breast cancer subtypes. Nature 2012, 486:405-409. doi: 10.1038/nature11154.
-
(2012)
Nature
, vol.486
, pp. 405-409
-
-
Banerji, S.1
Cibulskis, K.2
Rangel-Escareno, C.3
Brown, K.K.4
Carter, S.L.5
Frederick, A.M.6
Lawrence, M.S.7
Sivachenko, A.Y.8
Sougnez, C.9
Zou, L.10
-
154
-
-
0036141521
-
Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter its DNA-binding specificity
-
Filippova GN, Qi CF, Ulmer JE, Moore JM, Ward MD, Hu YJ, Loukinov DI, Pugacheva EM, Klenova EM, Grundy PE, et al. Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter its DNA-binding specificity. Cancer Res 2002, 62:48-52.
-
(2002)
Cancer Res
, vol.62
, pp. 48-52
-
-
Filippova, G.N.1
Qi, C.F.2
Ulmer, J.E.3
Moore, J.M.4
Ward, M.D.5
Hu, Y.J.6
Loukinov, D.I.7
Pugacheva, E.M.8
Klenova, E.M.9
Grundy, P.E.10
-
155
-
-
0036773376
-
Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas
-
doi: 10.1002/path.1121.
-
Gorgoulis VG, Zacharatos P, Mariatos G, Kotsinas A, Bouda M, Kletsas D, Asimacopoulos PJ, Agnantis N, Kittas C, Papavassiliou AG. Transcription factor E2F-1 acts as a growth-promoting factor and is associated with adverse prognosis in non-small cell lung carcinomas. J Pathol 2002, 198:142-156. doi: 10.1002/path.1121.
-
(2002)
J Pathol
, vol.198
, pp. 142-156
-
-
Gorgoulis, V.G.1
Zacharatos, P.2
Mariatos, G.3
Kotsinas, A.4
Bouda, M.5
Kletsas, D.6
Asimacopoulos, P.J.7
Agnantis, N.8
Kittas, C.9
Papavassiliou, A.G.10
-
156
-
-
34147224008
-
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
-
doi: 10.1038/nature05690.
-
Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD, Girtman K, Mathew S, Ma J, Pounds SB, et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007, 446:758-764. doi: 10.1038/nature05690.
-
(2007)
Nature
, vol.446
, pp. 758-764
-
-
Mullighan, C.G.1
Goorha, S.2
Radtke, I.3
Miller, C.B.4
Coustan-Smith, E.5
Dalton, J.D.6
Girtman, K.7
Mathew, S.8
Ma, J.9
Pounds, S.B.10
-
157
-
-
33845807801
-
Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities
-
doi: 10.1158/0008-5472.CAN-06-2072.
-
Maher EA, Brennan C, Wen PY, Durso L, Ligon KL, Richardson A, Khatry D, Feng B, Sinha R, Louis DN, et al. Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities. Cancer Res 2006, 66:11502-11513. doi: 10.1158/0008-5472.CAN-06-2072.
-
(2006)
Cancer Res
, vol.66
, pp. 11502-11513
-
-
Maher, E.A.1
Brennan, C.2
Wen, P.Y.3
Durso, L.4
Ligon, K.L.5
Richardson, A.6
Khatry, D.7
Feng, B.8
Sinha, R.9
Louis, D.N.10
-
158
-
-
84859631946
-
Gene amplification of ESR1 in breast cancers-fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study
-
doi: 10.1002/path.3974.
-
Ooi A, Inokuchi M, Harada S, Inazawa J, Tajiri R, Kitamura SS, Ikeda H, Kawashima H, Dobashi Y. Gene amplification of ESR1 in breast cancers-fact or fiction? A fluorescence in situ hybridization and multiplex ligation-dependent probe amplification study. J Pathol 2012, 227:8-16. doi: 10.1002/path.3974.
-
(2012)
J Pathol
, vol.227
, pp. 8-16
-
-
Ooi, A.1
Inokuchi, M.2
Harada, S.3
Inazawa, J.4
Tajiri, R.5
Kitamura, S.S.6
Ikeda, H.7
Kawashima, H.8
Dobashi, Y.9
-
159
-
-
74449093973
-
A comprehensive catalogue of somatic mutations from a human cancer genome
-
doi: 10.1038/nature08658.
-
Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, Varela I, Lin M-L, Ordóñez GR, Bignell GR, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010, 463:191-196. doi: 10.1038/nature08658.
-
(2010)
Nature
, vol.463
, pp. 191-196
-
-
Pleasance, E.D.1
Cheetham, R.K.2
Stephens, P.J.3
McBride, D.J.4
Humphray, S.J.5
Greenman, C.D.6
Varela, I.7
Lin, M.-L.8
Ordóñez, G.R.9
Bignell, G.R.10
-
160
-
-
84874660862
-
Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes
-
doi: 10.1007/s10549-013-2408-2.
-
Mesquita B, Lopes P, Rodrigues A, Pereira D, Afonso M, Leal C, Henrique R, Lind GE, Jerónimo C, Lothe RA, et al. Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypes. Breast Cancer Res Treat 2013, 138:37-45. doi: 10.1007/s10549-013-2408-2.
-
(2013)
Breast Cancer Res Treat
, vol.138
, pp. 37-45
-
-
Mesquita, B.1
Lopes, P.2
Rodrigues, A.3
Pereira, D.4
Afonso, M.5
Leal, C.6
Henrique, R.7
Lind, G.E.8
Jerónimo, C.9
Lothe, R.A.10
-
161
-
-
27344451557
-
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
-
doi: 10.1126/science.1117679.
-
Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun X-W, Varambally S, Cao X, Tchinda J, Kuefer R, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 2005, 310:644-648. doi: 10.1126/science.1117679.
-
(2005)
Science
, vol.310
, pp. 644-648
-
-
Tomlins, S.A.1
Rhodes, D.R.2
Perner, S.3
Dhanasekaran, S.M.4
Mehra, R.5
Sun, X.-W.6
Varambally, S.7
Cao, X.8
Tchinda, J.9
Kuefer, R.10
-
162
-
-
84870376109
-
Cancer genetics and genomics of human {FOX} family genes
-
doi: 10.1016/j.canlet.2012.09.017.
-
Katoh M, Igarashi M, Fukuda H, Nakagama H, Katoh M. Cancer genetics and genomics of human {FOX} family genes. Cancer Lett 2013, 328:198-206. doi: 10.1016/j.canlet.2012.09.017.
-
(2013)
Cancer Lett
, vol.328
, pp. 198-206
-
-
Katoh, M.1
Igarashi, M.2
Fukuda, H.3
Nakagama, H.4
Katoh, M.5
-
163
-
-
84864054209
-
GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia
-
doi: 10.1182/blood-2012-01-403220.
-
Greif PA, Dufour A, Konstandin NP, Ksienzyk B, Zellmeier E, Tizazu B, Sturm J, Benthaus T, Herold T, Yaghmaie M, et al. GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia. Blood 2012, 120:395-403. doi: 10.1182/blood-2012-01-403220.
-
(2012)
Blood
, vol.120
, pp. 395-403
-
-
Greif, P.A.1
Dufour, A.2
Konstandin, N.P.3
Ksienzyk, B.4
Zellmeier, E.5
Tizazu, B.6
Sturm, J.7
Benthaus, T.8
Herold, T.9
Yaghmaie, M.10
-
164
-
-
84877036815
-
GATA3 mutations found in breast cancers may be associated with aberrant nuclear localization, reduced transactivation and cell invasiveness
-
doi: 10.1007/s12672-013-0138-x.
-
Gaynor KU, Grigorieva IV, Allen MD, Esapa CT, Head RA, Gopinath P, Christie PT, Nesbit MA, Jones JL, Thakker RV. GATA3 mutations found in breast cancers may be associated with aberrant nuclear localization, reduced transactivation and cell invasiveness. Horm Cancer 2013, 4:123-139. doi: 10.1007/s12672-013-0138-x.
-
(2013)
Horm Cancer
, vol.4
, pp. 123-139
-
-
Gaynor, K.U.1
Grigorieva, I.V.2
Allen, M.D.3
Esapa, C.T.4
Head, R.A.5
Gopinath, P.6
Christie, P.T.7
Nesbit, M.A.8
Jones, J.L.9
Thakker, R.V.10
-
165
-
-
33748870952
-
Hypermethylation of the GATA gene family in esophageal cancer
-
doi: 10.1002/ijc.22092.
-
Guo M, House MG, Akiyama Y, Qi Y, Capagna D, Harmon J, Baylin SB, Brock MV, Herman JG. Hypermethylation of the GATA gene family in esophageal cancer. Int J Cancer 2006, 119:2078-2083. doi: 10.1002/ijc.22092.
-
(2006)
Int J Cancer
, vol.119
, pp. 2078-2083
-
-
Guo, M.1
House, M.G.2
Akiyama, Y.3
Qi, Y.4
Capagna, D.5
Harmon, J.6
Baylin, S.B.7
Brock, M.V.8
Herman, J.G.9
-
166
-
-
33748297582
-
Histone modifications silence the GATA transcription factor genes in ovarian cancer
-
doi: 10.1038/sj.onc.1209533.
-
Caslini C, Capo-chichi CD, Roland IH, Nicolas E, Yeung AT, Xu X-X. Histone modifications silence the GATA transcription factor genes in ovarian cancer. Oncogene 2006, 25:5446-5461. doi: 10.1038/sj.onc.1209533.
-
(2006)
Oncogene
, vol.25
, pp. 5446-5461
-
-
Caslini, C.1
Capo-chichi, C.D.2
Roland, I.H.3
Nicolas, E.4
Yeung, A.T.5
Xu, X.-X.6
-
167
-
-
84867886926
-
{GATA} binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor
-
doi: 10.1016/j.humpath.2012.02.011.
-
Miyamoto H, Izumi K, Yao JL, Li Y, Yang Q, McMahon LA, Gonzalez-Roibon N, Hicks DG, Tacha D, Netto GJ. {GATA} binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumor. Hum Pathol 2012, 43:2033-2040. doi: 10.1016/j.humpath.2012.02.011.
-
(2012)
Hum Pathol
, vol.43
, pp. 2033-2040
-
-
Miyamoto, H.1
Izumi, K.2
Yao, J.L.3
Li, Y.4
Yang, Q.5
McMahon, L.A.6
Gonzalez-Roibon, N.7
Hicks, D.G.8
Tacha, D.9
Netto, G.J.10
-
168
-
-
0036648241
-
Mutations in SUFU predispose to medulloblastoma
-
doi: 10.1038/ng916.
-
Taylor MD, Liu L, Raffel C, Hui C-C, Mainprize TG, Zhang X, Agatep R, Chiappa S, Gao L, Lowrance A, et al. Mutations in SUFU predispose to medulloblastoma. Nat Genet 2002, 31:306. doi: 10.1038/ng916.
-
(2002)
Nat Genet
, vol.31
, pp. 306
-
-
Taylor, M.D.1
Liu, L.2
Raffel, C.3
Hui, C.-C.4
Mainprize, T.G.5
Zhang, X.6
Agatep, R.7
Chiappa, S.8
Gao, L.9
Lowrance, A.10
-
169
-
-
84865694593
-
Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia
-
doi: 10.1056/NEJMoa1205119.
-
Zhuang Z, Yang C, Lorenzo F, Merino M, Fojo T, Kebebew E, Popovic V, Stratakis CA, Prchal JT, Pacak K. Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N Engl J Med 2012, 367:922-930. doi: 10.1056/NEJMoa1205119.
-
(2012)
N Engl J Med
, vol.367
, pp. 922-930
-
-
Zhuang, Z.1
Yang, C.2
Lorenzo, F.3
Merino, M.4
Fojo, T.5
Kebebew, E.6
Popovic, V.7
Stratakis, C.A.8
Prchal, J.T.9
Pacak, K.10
-
170
-
-
6344252624
-
Mutation of TCF1 encoding hepatocyte nuclear factor 1α in gynecological cancer
-
doi: 10.1038/sj.onc.1207989.
-
Rebouissou S, Rosty C, Lecuru F, Boisselier S, Bui H, Frere-Belfa M-AL, Sastre X, Laurent-Puig P, Zucman-Rossi J. Mutation of TCF1 encoding hepatocyte nuclear factor 1α in gynecological cancer. Oncogene 2004, 23:7588-7592. doi: 10.1038/sj.onc.1207989.
-
(2004)
Oncogene
, vol.23
, pp. 7588-7592
-
-
Rebouissou, S.1
Rosty, C.2
Lecuru, F.3
Boisselier, S.4
Bui, H.5
Frere-Belfa, M.-A.6
Sastre, X.7
Laurent-Puig, P.8
Zucman-Rossi, J.9
-
171
-
-
0842329848
-
Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer
-
doi: 10.1038/sj.onc.1207067.
-
Zhao W, Hisamuddin IM, Nandan MO, Babbin BA, Lamb NE, Yang VW. Identification of Krüppel-like factor 4 as a potential tumor suppressor gene in colorectal cancer. Oncogene 2004, 23:395-402. doi: 10.1038/sj.onc.1207067.
-
(2004)
Oncogene
, vol.23
, pp. 395-402
-
-
Zhao, W.1
Hisamuddin, I.M.2
Nandan, M.O.3
Babbin, B.A.4
Lamb, N.E.5
Yang, V.W.6
-
172
-
-
0344127550
-
Deletion, mutation, and loss of expression of KLF6 in human prostate cancer
-
doi: 10.1016/S0002-9440(10)63930-2.
-
Chen C, Hyytinen ER, Sun X, Helin HJ, Koivisto PA, Frierson HF, Vessella RL, Dong JT. Deletion, mutation, and loss of expression of KLF6 in human prostate cancer. Am J Pathol 2003, 162:1349-1354. doi: 10.1016/S0002-9440(10)63930-2.
-
(2003)
Am J Pathol
, vol.162
, pp. 1349-1354
-
-
Chen, C.1
Hyytinen, E.R.2
Sun, X.3
Helin, H.J.4
Koivisto, P.A.5
Frierson, H.F.6
Vessella, R.L.7
Dong, J.T.8
-
173
-
-
2542521484
-
Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells
-
doi: 10.1158/0008-5472.CAN-04-0185.
-
Ito G, Uchiyama M, Kondo M, Mori S, Usami N, Maeda O, Kawabe T, Hasegawa Y, Shimokata K, Sekido Y. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells. Cancer Res 2004, 64:3838-3843. doi: 10.1158/0008-5472.CAN-04-0185.
-
(2004)
Cancer Res
, vol.64
, pp. 3838-3843
-
-
Ito, G.1
Uchiyama, M.2
Kondo, M.3
Mori, S.4
Usami, N.5
Maeda, O.6
Kawabe, T.7
Hasegawa, Y.8
Shimokata, K.9
Sekido, Y.10
-
174
-
-
82555187007
-
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
-
doi: 10.1038/nature10630.
-
Yokoyama S, Woods SL, Boyle GM, Aoude LG, MacGregor S, Zismann V, Gartside M, Cust AE, Haq R, Harland M, et al. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature 2011, 480:99-103. doi: 10.1038/nature10630.
-
(2011)
Nature
, vol.480
, pp. 99-103
-
-
Yokoyama, S.1
Woods, S.L.2
Boyle, G.M.3
Aoude, L.G.4
MacGregor, S.5
Zismann, V.6
Gartside, M.7
Cust, A.E.8
Haq, R.9
Harland, M.10
-
175
-
-
73249115584
-
Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck
-
doi: 10.1073/pnas.0909114106.
-
Persson M, Andrén Y, Mark J, Horlings HM, Persson F, Stenman G. Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA 2009, 106:18740-18744. doi: 10.1073/pnas.0909114106.
-
(2009)
Proc Natl Acad Sci USA
, vol.106
, pp. 18740-18744
-
-
Persson, M.1
Andrén, Y.2
Mark, J.3
Horlings, H.M.4
Persson, F.5
Stenman, G.6
-
176
-
-
33748192942
-
The Myc oncoprotein as a therapeutic target for human cancer
-
doi: 10.1016/j.semcancer.2006.07.015.
-
Vita M, Henriksson M. The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 2006, 16:318-330. doi: 10.1016/j.semcancer.2006.07.015.
-
(2006)
Semin Cancer Biol
, vol.16
, pp. 318-330
-
-
Vita, M.1
Henriksson, M.2
-
177
-
-
34250898562
-
NF-kappaB as a potential molecular target for cancer therapy
-
Lee CH, Jeon YT, Kim SH, Song YS. NF-kappaB as a potential molecular target for cancer therapy. Biofactors 2007, 29:19-35.
-
(2007)
Biofactors
, vol.29
, pp. 19-35
-
-
Lee, C.H.1
Jeon, Y.T.2
Kim, S.H.3
Song, Y.S.4
-
178
-
-
0042160177
-
Identification and characterization of p100HB, a new mutant form of p100/NF-kappa B2
-
Derudder E, Laferté A, Ferreira V, Mishal Z, Baud V, Tarantino N, Körner M. Identification and characterization of p100HB, a new mutant form of p100/NF-kappa B2. Biochem Biophys Res Commun 2003, 308:744-749.
-
(2003)
Biochem Biophys Res Commun
, vol.308
, pp. 744-749
-
-
Derudder, E.1
Laferté, A.2
Ferreira, V.3
Mishal, Z.4
Baud, V.5
Tarantino, N.6
Körner, M.7
-
179
-
-
36248980204
-
Characterizing the cancer genome in lung adenocarcinoma
-
doi: 10.1038/nature06358.
-
Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R, Lin WM, Province MA, Kraja A, Johnson LA, et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 2007, 450:893-898. doi: 10.1038/nature06358.
-
(2007)
Nature
, vol.450
, pp. 893-898
-
-
Weir, B.A.1
Woo, M.S.2
Getz, G.3
Perner, S.4
Ding, L.5
Beroukhim, R.6
Lin, W.M.7
Province, M.A.8
Kraja, A.9
Johnson, L.A.10
-
180
-
-
63549121490
-
{NRF2} and {KEAP1} mutations: permanent activation of an adaptive response in cancer
-
doi: 10.1016/j.tibs.2008.12.008.
-
Hayes JD, McMahon M. {NRF2} and {KEAP1} mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci 2009, 34:176-188. doi: 10.1016/j.tibs.2008.12.008.
-
(2009)
Trends Biochem Sci
, vol.34
, pp. 176-188
-
-
Hayes, J.D.1
McMahon, M.2
-
181
-
-
84871519753
-
The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistance
-
doi: 10.1182/blood-2012-04-422121.
-
Rushworth SA, Zaitseva L, Murray MY, Shah NM, Bowles KM, MacEwan DJ. The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistance. Blood 2012, 120:5188-5198. doi: 10.1182/blood-2012-04-422121.
-
(2012)
Blood
, vol.120
, pp. 5188-5198
-
-
Rushworth, S.A.1
Zaitseva, L.2
Murray, M.Y.3
Shah, N.M.4
Bowles, K.M.5
MacEwan, D.J.6
-
182
-
-
70450255241
-
PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study
-
doi: 10.1038/leu.2009.135.
-
Familiades J, Bousquet M, Lafage-Pochitaloff M, Béné C, Beldjord K, De Vos J, Dastugue N, Coyaud E, Struski S, Quelen C, et al. PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL study. Leukemia 2009, 23:1989-1998. doi: 10.1038/leu.2009.135.
-
(2009)
Leukemia
, vol.23
, pp. 1989-1998
-
-
Familiades, J.1
Bousquet, M.2
Lafage-Pochitaloff, M.3
Béné, C.4
Beldjord, K.5
De Vos, J.6
Dastugue, N.7
Coyaud, E.8
Struski, S.9
Quelen, C.10
-
183
-
-
2642519463
-
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1
-
doi: 10.1038/ng1361.
-
Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Beau MML, Okuno Y, Akashi K, Fiering S, Tenen DG. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet 2004, 36:624. doi: 10.1038/ng1361.
-
(2004)
Nat Genet
, vol.36
, pp. 624
-
-
Rosenbauer, F.1
Wagner, K.2
Kutok, J.L.3
Iwasaki, H.4
Beau, M.M.L.5
Okuno, Y.6
Akashi, K.7
Fiering, S.8
Tenen, D.G.9
-
184
-
-
24044500329
-
Retinoid receptors in ovarian cancer: expression and prognosis
-
doi: 10.1093/annonc/mdi265.
-
Kaiser PC, Körner M, Kappeler A, Aebi S. Retinoid receptors in ovarian cancer: expression and prognosis. Ann Oncol 2005, 16:1477-1487. doi: 10.1093/annonc/mdi265.
-
(2005)
Ann Oncol
, vol.16
, pp. 1477-1487
-
-
Kaiser, P.C.1
Körner, M.2
Kappeler, A.3
Aebi, S.4
-
185
-
-
0037428658
-
Retinoic acid receptor-alpha as a prognostic indicator in oral squamous cell carcinoma
-
doi: 10.1002/ijc.10819.
-
Chakravarti N, Mathur M, Bahadur S, Kumar Shukla N, Ralhan R. Retinoic acid receptor-alpha as a prognostic indicator in oral squamous cell carcinoma. Int J Cancer 2003, 103:544-549. doi: 10.1002/ijc.10819.
-
(2003)
Int J Cancer
, vol.103
, pp. 544-549
-
-
Chakravarti, N.1
Mathur, M.2
Bahadur, S.3
Kumar Shukla, N.4
Ralhan, R.5
-
186
-
-
0034480284
-
Immunohistochemical detection of retinoic acid receptor-alpha in prostate carcinoma: correlation with proliferative activity and tumor grade
-
Gyftopoulos K, Perimenis P, Sotiropoulou-Bonikou G, Sakellaropoulos G, Varakis I, Barbalias GA. Immunohistochemical detection of retinoic acid receptor-alpha in prostate carcinoma: correlation with proliferative activity and tumor grade. Int Urol Nephrol 2000, 32:263-269.
-
(2000)
Int Urol Nephrol
, vol.32
, pp. 263-269
-
-
Gyftopoulos, K.1
Perimenis, P.2
Sotiropoulou-Bonikou, G.3
Sakellaropoulos, G.4
Varakis, I.5
Barbalias, G.A.6
-
187
-
-
0029992936
-
Immunohistochemical analysis of retinoic acid receptor-alpha in human breast tumors: retinoic acid receptor-alpha expression correlates with proliferative activity
-
van der Leede BM, Geertzema J, Vroom TM, Décimo D, Lutz Y, van der Saag PT, van der Burg B. Immunohistochemical analysis of retinoic acid receptor-alpha in human breast tumors: retinoic acid receptor-alpha expression correlates with proliferative activity. Am J Pathol 1996, 148:1905-1914.
-
(1996)
Am J Pathol
, vol.148
, pp. 1905-1914
-
-
van der Leede, B.M.1
Geertzema, J.2
Vroom, T.M.3
Décimo, D.4
Lutz, Y.5
van der Saag, P.T.6
van der Burg, B.7
-
188
-
-
0033559746
-
Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias
-
Osato M, Asou N, Abdalla E, Hoshino K, Yamasaki H, Okubo T, Suzushima H, Takatsuki K, Kanno T, Shigesada K, et al. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. Blood 1999, 93:1817-1824.
-
(1999)
Blood
, vol.93
, pp. 1817-1824
-
-
Osato, M.1
Asou, N.2
Abdalla, E.3
Hoshino, K.4
Yamasaki, H.5
Okubo, T.6
Suzushima, H.7
Takatsuki, K.8
Kanno, T.9
Shigesada, K.10
-
189
-
-
0025746321
-
t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1
-
Miyoshi H, Shimizu K, Kozu T, Maseki N, Kaneko Y, Ohki M. t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sci USA 1991, 88:10431-10434.
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 10431-10434
-
-
Miyoshi, H.1
Shimizu, K.2
Kozu, T.3
Maseki, N.4
Kaneko, Y.5
Ohki, M.6
-
190
-
-
18344389720
-
Causal relationship between the loss of RUNX3 expression and gastric cancer
-
Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002, 109:113-124.
-
(2002)
Cell
, vol.109
, pp. 113-124
-
-
Li, Q.L.1
Ito, K.2
Sakakura, C.3
Fukamachi, H.4
Inoue, K.5
Chi, X.Z.6
Lee, K.Y.7
Nomura, S.8
Lee, C.W.9
Han, S.B.10
-
191
-
-
79957897561
-
SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation
-
doi: 10.1186/1471-2407-11-223.
-
Acun T, Oztas E, Yagci T, Yakicier MC. SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation. BMC Cancer 2011, 11:223. doi: 10.1186/1471-2407-11-223.
-
(2011)
BMC Cancer
, vol.11
, pp. 223
-
-
Acun, T.1
Oztas, E.2
Yagci, T.3
Yakicier, M.C.4
-
192
-
-
74949090477
-
Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma
-
doi: 10.1002/gcc.20714.
-
Freier K, Knoepfle K, Flechtenmacher C, Pungs S, Devens F, Toedt G, Hofele C, Joos S, Lichter P, Radlwimmer B. Recurrent copy number gain of transcription factor SOX2 and corresponding high protein expression in oral squamous cell carcinoma. Genes Chromosomes Cancer 2010, 49:9-16. doi: 10.1002/gcc.20714.
-
(2010)
Genes Chromosomes Cancer
, vol.49
, pp. 9-16
-
-
Freier, K.1
Knoepfle, K.2
Flechtenmacher, C.3
Pungs, S.4
Devens, F.5
Toedt, G.6
Hofele, C.7
Joos, S.8
Lichter, P.9
Radlwimmer, B.10
-
193
-
-
63149120518
-
The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer
-
doi: 10.1093/hmg/ddp034.
-
Medina PP, Castillo SD, Blanco S, Sanz-Garcia M, Largo C, Alvarez S, Yokota J, Gonzalez-Neira A, Benitez J, Clevers HC, et al. The SRY-HMG box gene, SOX4, is a target of gene amplification at chromosome 6p in lung cancer. Hum Mol Genet 2009, 18:1343-1352. doi: 10.1093/hmg/ddp034.
-
(2009)
Hum Mol Genet
, vol.18
, pp. 1343-1352
-
-
Medina, P.P.1
Castillo, S.D.2
Blanco, S.3
Sanz-Garcia, M.4
Largo, C.5
Alvarez, S.6
Yokota, J.7
Gonzalez-Neira, A.8
Benitez, J.9
Clevers, H.C.10
-
194
-
-
84878221509
-
STAT5A/B gene locus undergoes amplification during human prostate cancer progression
-
doi: 10.1016/j.ajpath.2013.02.044.
-
Haddad BR, Gu L, Mirtti T, Dagvadorj A, Vogiatzi P, Hoang DT, Bajaj R, Leiby B, Ellsworth E, Blackmon S, et al. STAT5A/B gene locus undergoes amplification during human prostate cancer progression. Am J Pathol 2013, 182:2264-2275. doi: 10.1016/j.ajpath.2013.02.044.
-
(2013)
Am J Pathol
, vol.182
, pp. 2264-2275
-
-
Haddad, B.R.1
Gu, L.2
Mirtti, T.3
Dagvadorj, A.4
Vogiatzi, P.5
Hoang, D.T.6
Bajaj, R.7
Leiby, B.8
Ellsworth, E.9
Blackmon, S.10
-
195
-
-
79960346759
-
Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas
-
doi: 10.1084/jem.20110283.
-
Pilati C, Amessou M, Bihl MP, Balabaud C, Nhieu JT, Paradis V, Nault JC, Izard T, Bioulac-Sage P, Couchy G, et al. Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. J Exp Med 2011, 208:1359-1366. doi: 10.1084/jem.20110283.
-
(2011)
J Exp Med
, vol.208
, pp. 1359-1366
-
-
Pilati, C.1
Amessou, M.2
Bihl, M.P.3
Balabaud, C.4
Nhieu, J.T.5
Paradis, V.6
Nault, J.C.7
Izard, T.8
Bioulac-Sage, P.9
Couchy, G.10
-
196
-
-
79951895134
-
Loss-of-function mutations in the transcription factor 7 (T cell factor-1) gene in hepatogastrointestinal cancers
-
doi: 10.1007/s13273-010-0037-y.
-
Jung KH, Yoon KJ, Song JH, Lee SH, Eun JW, Noh JH, Kim JK, Bae HJ, Lee JE, Kim SW, et al. Loss-of-function mutations in the transcription factor 7 (T cell factor-1) gene in hepatogastrointestinal cancers. Mol Cell Toxicol 2010, 6:271-278. doi: 10.1007/s13273-010-0037-y.
-
(2010)
Mol Cell Toxicol
, vol.6
, pp. 271-278
-
-
Jung, K.H.1
Yoon, K.J.2
Song, J.H.3
Lee, S.H.4
Eun, J.W.5
Noh, J.H.6
Kim, J.K.7
Bae, H.J.8
Lee, J.E.9
Kim, S.W.10
-
197
-
-
0034675276
-
Amplification and overexpression of TGIF2, a novel homeobox gene of the {TALE} superclass, in ovarian cancer cell lines
-
doi: 10.1006/bbrc.2000.3449.
-
Imoto I, Pimkhaokham A, Watanabe T, Saito-Ohara F, Soeda E, Inazawa J. Amplification and overexpression of TGIF2, a novel homeobox gene of the {TALE} superclass, in ovarian cancer cell lines. Biochem Biophys Res Commun 2000, 276:264-270. doi: 10.1006/bbrc.2000.3449.
-
(2000)
Biochem Biophys Res Commun
, vol.276
, pp. 264-270
-
-
Imoto, I.1
Pimkhaokham, A.2
Watanabe, T.3
Saito-Ohara, F.4
Soeda, E.5
Inazawa, J.6
-
198
-
-
58449090870
-
TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival
-
doi: 10.1002/path.2443.
-
Perner S, Wagner PL, Soltermann A, LaFargue C, Tischler V, Weir BA, Weder W, Meyerson M, Giordano TJ, Moch H, et al. TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival. J Pathol 2009, 217:65-72. doi: 10.1002/path.2443.
-
(2009)
J Pathol
, vol.217
, pp. 65-72
-
-
Perner, S.1
Wagner, P.L.2
Soltermann, A.3
LaFargue, C.4
Tischler, V.5
Weir, B.A.6
Weder, W.7
Meyerson, M.8
Giordano, T.J.9
Moch, H.10
-
199
-
-
33644507479
-
Transcription factor YY1: structure, function, and therapeutic implications in cancer biology
-
doi: 10.1038/sj.onc.1209080.
-
Gordon S, Akopyan G, Garban H, Bonavida B. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology. Oncogene 2006, 25:1125-1142. doi: 10.1038/sj.onc.1209080.
-
(2006)
Oncogene
, vol.25
, pp. 1125-1142
-
-
Gordon, S.1
Akopyan, G.2
Garban, H.3
Bonavida, B.4
-
200
-
-
78650117262
-
Increase of ZASC1 gene copy number in recurrent oral carcinoma
-
doi: 10.1111/j.1601-0825.2010.01702.x.
-
Chiang W-F, Hung P-S, Liu S-Y, Yuan T-C, Chang K-W, Chen Y-P, Liu Y-C, Lin S-C. Increase of ZASC1 gene copy number in recurrent oral carcinoma. Oral Dis 2011, 17:53-59. doi: 10.1111/j.1601-0825.2010.01702.x.
-
(2011)
Oral Dis
, vol.17
, pp. 53-59
-
-
Chiang, W.-F.1
Hung, P.-S.2
Liu, S.-Y.3
Yuan, T.-C.4
Chang, K.-W.5
Chen, Y.-P.6
Liu, Y.-C.7
Lin, S.-C.8
-
201
-
-
33745918951
-
TIGAR, a p53-inducible regulator of glycolysis and apoptosis
-
doi: 10.1016/j.cell.2006.05.036.
-
Bensaad K, Tsuruta A, Selak MA, Vidal MNC, Nakano K, Bartrons R, Gottlieb E, Vousden KH. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006, 126:107-120. doi: 10.1016/j.cell.2006.05.036.
-
(2006)
Cell
, vol.126
, pp. 107-120
-
-
Bensaad, K.1
Tsuruta, A.2
Selak, M.A.3
Vidal, M.N.C.4
Nakano, K.5
Bartrons, R.6
Gottlieb, E.7
Vousden, K.H.8
-
202
-
-
0028961442
-
Expression of the wild-type p53 antioncogene induces guanine nucleotide-dependent stem cell division kinetics
-
Sherley JL, Stadler PB, Johnson DR. Expression of the wild-type p53 antioncogene induces guanine nucleotide-dependent stem cell division kinetics. Proc Natl Acad Sci USA 1995, 92:136-140.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 136-140
-
-
Sherley, J.L.1
Stadler, P.B.2
Johnson, D.R.3
-
203
-
-
33745149291
-
p53 regulates mitochondrial respiration
-
doi: 10.1126/science.1126863.
-
Matoba S, Kang J-G, Patino WD, Wragg A, Boehm M, Gavrilova O, Hurley PJ, Bunz F, Hwang PM. p53 regulates mitochondrial respiration. Science 2006, 312:1650-1653. doi: 10.1126/science.1126863.
-
(2006)
Science
, vol.312
, pp. 1650-1653
-
-
Matoba, S.1
Kang, J.-G.2
Patino, W.D.3
Wragg, A.4
Boehm, M.5
Gavrilova, O.6
Hurley, P.J.7
Bunz, F.8
Hwang, P.M.9
-
204
-
-
34047205431
-
Mutant p53: an oncogenic transcription factor
-
doi: 10.1038/sj.onc.1210296.
-
Strano S, Dell'Orso S, Di Agostino S, Fontemaggi G, Sacchi A, Blandino G. Mutant p53: an oncogenic transcription factor. Oncogene 2007, 26:2212-2219. doi: 10.1038/sj.onc.1210296.
-
(2007)
Oncogene
, vol.26
, pp. 2212-2219
-
-
Strano, S.1
Dell'Orso, S.2
Di Agostino, S.3
Fontemaggi, G.4
Sacchi, A.5
Blandino, G.6
-
205
-
-
77149146794
-
A common gain of function of p53 cancer mutants in inducing genetic instability
-
doi: 10.1038/onc.2009.376.
-
Liu DP, Song H, Xu Y. A common gain of function of p53 cancer mutants in inducing genetic instability. Oncogene 2010, 29:949-956. doi: 10.1038/onc.2009.376.
-
(2010)
Oncogene
, vol.29
, pp. 949-956
-
-
Liu, D.P.1
Song, H.2
Xu, Y.3
-
206
-
-
13644260907
-
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
-
doi: 10.1016/j.cell.2004.11.006.
-
Lang GA, Iwakuma T, Suh Y-A, Liu G, Rao VA, Parant JM, Valentin-Vega YA, Terzian T, Caldwell LC, Strong LC, et al. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 2004, 119:861-872. doi: 10.1016/j.cell.2004.11.006.
-
(2004)
Cell
, vol.119
, pp. 861-872
-
-
Lang, G.A.1
Iwakuma, T.2
Suh, Y.-A.3
Liu, G.4
Rao, V.A.5
Parant, J.M.6
Valentin-Vega, Y.A.7
Terzian, T.8
Caldwell, L.C.9
Strong, L.C.10
-
207
-
-
0025984266
-
Translocations, master genes, and differences between the origins of acute and chronic leukemias
-
doi: 10.1016/0092-8674(91)90057-6.
-
Rabbitts TH. Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell 1991, 67:641-644. doi: 10.1016/0092-8674(91)90057-6.
-
(1991)
Cell
, vol.67
, pp. 641-644
-
-
Rabbitts, T.H.1
-
208
-
-
0035868342
-
Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN
-
doi: 10.1038/sj.onc.1204257.
-
Pianetti S, Arsura M, Romieu-Mourez R, Coffey RJ, Sonenshein GE. Her-2/neu overexpression induces NF-kappaB via a PI3-kinase/Akt pathway involving calpain-mediated degradation of IkappaB-alpha that can be inhibited by the tumor suppressor PTEN. Oncogene 2001, 20:1287-1299. doi: 10.1038/sj.onc.1204257.
-
(2001)
Oncogene
, vol.20
, pp. 1287-1299
-
-
Pianetti, S.1
Arsura, M.2
Romieu-Mourez, R.3
Coffey, R.J.4
Sonenshein, G.E.5
-
209
-
-
75749124332
-
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
-
doi: 10.1038/ng.518.
-
Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R, Paul JE, Boyle M, Woolcock BW, Kuchenbauer F, et al. Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 2010, 42:181-185. doi: 10.1038/ng.518.
-
(2010)
Nat Genet
, vol.42
, pp. 181-185
-
-
Morin, R.D.1
Johnson, N.A.2
Severson, T.M.3
Mungall, A.J.4
An, J.5
Goya, R.6
Paul, J.E.7
Boyle, M.8
Woolcock, B.W.9
Kuchenbauer, F.10
-
210
-
-
84865790047
-
An integrated encyclopedia of DNA elements in the human genome
-
Dunham I, Birney E, Lajoie BR, Sanyal A, Dong X, Greven M, Lin X, Wang J, Whitfield TW, Zhuang J. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
-
(2012)
Nature
, vol.489
, pp. 57-74
-
-
Dunham, I.1
Birney, E.2
Lajoie, B.R.3
Sanyal, A.4
Dong, X.5
Greven, M.6
Lin, X.7
Wang, J.8
Whitfield, T.W.9
Zhuang, J.10
-
211
-
-
84875847924
-
Is junk DNA bunk? A critique of ENCODE
-
Doolittle WF. Is junk DNA bunk? A critique of ENCODE. Proc Natl Acad Sci USA 2013, 110:5294-5300.
-
(2013)
Proc Natl Acad Sci USA
, vol.110
, pp. 5294-5300
-
-
Doolittle, W.F.1
-
212
-
-
18144364301
-
Impairment of stromelysin-1 transcriptional activity by promoter mutations in high microsatellite instability colorectal tumors
-
doi: 10.1158/0008-5472.CAN-04-4442.
-
Morán A, Iniesta P, de Juan C, García-Aranda C, Díaz-López A, Benito M. Impairment of stromelysin-1 transcriptional activity by promoter mutations in high microsatellite instability colorectal tumors. Cancer Res 2005, 65:3811-3814. doi: 10.1158/0008-5472.CAN-04-4442.
-
(2005)
Cancer Res
, vol.65
, pp. 3811-3814
-
-
Morán, A.1
Iniesta, P.2
de Juan, C.3
García-Aranda, C.4
Díaz-López, A.5
Benito, M.6
-
213
-
-
84874189784
-
Highly recurrent TERT promoter mutations in human melanoma
-
Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science 2013, 339:957-959.
-
(2013)
Science
, vol.339
, pp. 957-959
-
-
Huang, F.W.1
Hodis, E.2
Xu, M.J.3
Kryukov, G.V.4
Chin, L.5
Garraway, L.A.6
-
214
-
-
84874191269
-
TERT promoter mutations in familial and sporadic melanoma
-
Horn S, Figl A, Rachakonda PS, Fischer C, Sucker A, Gast A, Kadel S, Moll I, Nagore E, Hemminki K. TERT promoter mutations in familial and sporadic melanoma. Science 2013, 339:959-961.
-
(2013)
Science
, vol.339
, pp. 959-961
-
-
Horn, S.1
Figl, A.2
Rachakonda, P.S.3
Fischer, C.4
Sucker, A.5
Gast, A.6
Kadel, S.7
Moll, I.8
Nagore, E.9
Hemminki, K.10
-
215
-
-
84877967061
-
Highly prevalent TERT promoter mutations in bladder cancer and brain glioblastoma
-
Liu X, Wu G, Hartmann C, Xing M. Highly prevalent TERT promoter mutations in bladder cancer and brain glioblastoma. Cell Cycle 2013, 12:0-1.
-
(2013)
Cell Cycle
, vol.12
, pp. 0-1
-
-
Liu, X.1
Wu, G.2
Hartmann, C.3
Xing, M.4
-
216
-
-
84882805198
-
Highly prevalent TERT promoter mutations in aggressive thyroid cancers
-
doi: 10.1530/ERC-13-0210.
-
Liu X, Bishop J, Shan Y, Pai S, Liu D, Murugan AK, Sun H, El-Naggar A, Xing M. Highly prevalent TERT promoter mutations in aggressive thyroid cancers. Endocr Relat Cancer 2013, 20:603-610. doi: 10.1530/ERC-13-0210.
-
(2013)
Endocr Relat Cancer
, vol.20
, pp. 603-610
-
-
Liu, X.1
Bishop, J.2
Shan, Y.3
Pai, S.4
Liu, D.5
Murugan, A.K.6
Sun, H.7
El-Naggar, A.8
Xing, M.9
-
217
-
-
77956295666
-
An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer
-
doi: 10.1101/gr.105361.110.
-
Wasserman NF, Aneas I, Nobrega MA. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. Genome Res 2010, 20:1191-1197. doi: 10.1101/gr.105361.110.
-
(2010)
Genome Res
, vol.20
, pp. 1191-1197
-
-
Wasserman, N.F.1
Aneas, I.2
Nobrega, M.A.3
-
218
-
-
84870531459
-
A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer
-
doi: 10.1038/ng.2437.
-
Gudmundsson J, Sulem P, Gudbjartsson DF, Masson G, Agnarsson BA, Benediktsdottir KR, Sigurdsson A, Magnusson OT, Gudjonsson SA, Magnusdottir DN, et al. A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer. Nat Genet 2012, 44:1326-1329. doi: 10.1038/ng.2437.
-
(2012)
Nat Genet
, vol.44
, pp. 1326-1329
-
-
Gudmundsson, J.1
Sulem, P.2
Gudbjartsson, D.F.3
Masson, G.4
Agnarsson, B.A.5
Benediktsdottir, K.R.6
Sigurdsson, A.7
Magnusson, O.T.8
Gudjonsson, S.A.9
Magnusdottir, D.N.10
-
219
-
-
34247860920
-
Mechanisms of Disease: methyl-binding domain proteins as potential therapeutic targets in cancer
-
doi: 10.1038/ncponc0812.
-
Sansom OJ, Maddison K, Clarke AR. Mechanisms of Disease: methyl-binding domain proteins as potential therapeutic targets in cancer. Nat Clin Pract Oncol 2007, 4:305-315. doi: 10.1038/ncponc0812.
-
(2007)
Nat Clin Pract Oncol
, vol.4
, pp. 305-315
-
-
Sansom, O.J.1
Maddison, K.2
Clarke, A.R.3
-
220
-
-
33847334699
-
Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome
-
doi: 10.1038/ng1966.
-
Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 2007, 39:311-318. doi: 10.1038/ng1966.
-
(2007)
Nat Genet
, vol.39
, pp. 311-318
-
-
Heintzman, N.D.1
Stuart, R.K.2
Hon, G.3
Fu, Y.4
Ching, C.W.5
Hawkins, R.D.6
Barrera, L.O.7
Van Calcar, S.8
Qu, C.9
Ching, K.A.10
|